BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20:389-391. [PMID: 32439870 DOI: 10.1038/s41577-020-0343-0] [Cited by in Crossref: 337] [Cited by in F6Publishing: 312] [Article Influence: 168.5] [Reference Citation Analysis]
Number Citing Articles
1 Frydman GH, Streiff MB, Connors JM, Piazza G. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. TH Open 2020;4:e288-99. [PMID: 33043235 DOI: 10.1055/s-0040-1718415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Lin JE, Asfour A, Sewell TB, Hooe B, Pryce P, Earley C, Shen MY, Kerner-Rossi M, Thakur KT, Vargas WS, Silver WG, Geneslaw AS. Neurological issues in children with COVID-19. Neurosci Lett 2021;743:135567. [PMID: 33352286 DOI: 10.1016/j.neulet.2020.135567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
3 Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev 2021;73:924-67. [PMID: 34088867 DOI: 10.1124/pharmrev.120.000096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Srivastava SP, Srivastava R, Chand S, Goodwin JE. Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals (Basel) 2021;14:751. [PMID: 34451848 DOI: 10.3390/ph14080751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin 2020;41:1539-46. [PMID: 33110240 DOI: 10.1038/s41401-020-00554-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 19.0] [Reference Citation Analysis]
6 Barajas-martínez A, Mehta R, Ibarra-coronado E, Fossion R, Martínez Garcés VJ, Arellano MR, González Alvarez IA, Bautista YVM, Bello-chavolla OY, Pedraza NR, Encinas BR, Carrión CIP, Ávila MIJ, Valladares-garcía JC, Vanegas-cedillo PE, Juárez DH, Vargas-vázquez A, Antonio-villa NE, Almeda-valdes P, Resendis-antonio O, Hiriart M, Frank A, Aguilar-salinas CA, Rivera AL. Physiological Network Is Disrupted in Severe COVID-19. Front Physiol 2022;13:848172. [DOI: 10.3389/fphys.2022.848172] [Reference Citation Analysis]
7 Allnoch L, Beythien G, Leitzen E, Becker K, Kaup FJ, Stanelle-Bertram S, Schaumburg B, Mounogou Kouassi N, Beck S, Zickler M, Herder V, Gabriel G, Baumgärtner W. Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters. Viruses 2021;13:639. [PMID: 33918079 DOI: 10.3390/v13040639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bossù P, Toppi E, Sterbini V, Spalletta G. Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic. J Pers Med 2020;10:E102. [PMID: 32858874 DOI: 10.3390/jpm10030102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
9 Smeda M, Chlopicki S. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc Res 2020;116:e118-21. [PMID: 32707576 DOI: 10.1093/cvr/cvaa190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
10 Janardhan V, Janardhan V, Kalousek V. COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy. J Neuroimaging 2020;30:555-61. [PMID: 32776617 DOI: 10.1111/jon.12770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
11 Hanchard J, Capó-Vélez CM, Deusch K, Lidington D, Bolz SS. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19. Front Endocrinol (Lausanne) 2020;11:583006. [PMID: 33101215 DOI: 10.3389/fendo.2020.583006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
13 Keane G, Dorman T. Fatal pulmonary thromboembolism in asymptomatic COVID-19. Ir J Med Sci 2021. [PMID: 34482482 DOI: 10.1007/s11845-021-02735-8] [Reference Citation Analysis]
14 Bunders MJ, Altfeld M. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Immunity 2020;53:487-95. [PMID: 32853545 DOI: 10.1016/j.immuni.2020.08.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
15 Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
16 Freitas F, Tibiriçá E, Singh M, Fraser PA, Mann GE. Redox Regulation of Microvascular Permeability: IL-1β Potentiation of Bradykinin-Induced Permeability Is Prevented by Simvastatin. Antioxidants (Basel) 2020;9:E1269. [PMID: 33327440 DOI: 10.3390/antiox9121269] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Varghese E, Samuel SM, Liskova A, Kubatka P, Büsselberg D. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing. PLoS Pathog 2021;17:e1009634. [PMID: 34157054 DOI: 10.1371/journal.ppat.1009634] [Reference Citation Analysis]
18 Rodriguez-Gonzalez M, Rodríguez-Campoy P, Sánchez-Códez M, Gutiérrez-Rosa I, Castellano-Martinez A, Rodríguez-Benítez A. New onset severe right ventricular failure associated with COVID-19 in a young infant without previous heart disease. Cardiol Young 2020;30:1346-9. [PMID: 32600496 DOI: 10.1017/S1047951120001857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
19 Wang SS, Zeng X, Wang YL, Dongzhi Z, Zhao YF, Chen YZ. Chinese Medicine Meets Conventional Medicine in Targeting COVID-19 Pathophysiology, Complications and Comorbidities. Chin J Integr Med 2022. [PMID: 35583580 DOI: 10.1007/s11655-022-3573-0] [Reference Citation Analysis]
20 Dixon L, McNamara C, Gaur P, Mallon D, Coughlan C, Tona F, Jan W, Wilson M, Jones B. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? Stroke Vasc Neurol 2020;5:315-22. [PMID: 33208493 DOI: 10.1136/svn-2020-000652] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
21 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Reference Citation Analysis]
22 Amersfoort J, Eelen G, Carmeliet P. Immunomodulation by endothelial cells - partnering up with the immune system? Nat Rev Immunol 2022. [PMID: 35288707 DOI: 10.1038/s41577-022-00694-4] [Reference Citation Analysis]
23 Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-chahhoud K, Kolahi A, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol 2022;12:785946. [DOI: 10.3389/fimmu.2021.785946] [Reference Citation Analysis]
24 Botta C, Indrieri A, Garofalo E, Biamonte F, Bruni A, Pasqua P, Cesario F, Costanzo FS, Longhini F, Mendicino F. COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm. Front Oncol 2020;10:599502. [PMID: 33489899 DOI: 10.3389/fonc.2020.599502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Casciola-Rosen L, Thiemann DR, Andrade F, Trejo Zambrano MI, Hooper JE, Leonard E, Spangler J, Cox AL, Machamer C, Sauer L, Laeyendecker O, Garibaldi BT, Ray SC, Mecoli C, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke W, Rothman RE, Pekosz A, Fenstermacher K, Wang Z, Zeger SL, Rosen A. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. medRxiv 2020:2020. [PMID: 33083808 DOI: 10.1101/2020.10.13.20211664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
26 Lockhart SM, O'Rahilly S. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020;1:33-42. [PMID: 32838359 DOI: 10.1016/j.medj.2020.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
27 Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res 2020;226:57-69. [PMID: 32827705 DOI: 10.1016/j.trsl.2020.08.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 33.5] [Reference Citation Analysis]
28 Gattinoni L, Marini JJ, Camporota L. The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology. Am J Respir Crit Care Med 2020;202:1079-80. [PMID: 32881583 DOI: 10.1164/rccm.202008-3142ED] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
29 Abdelhadi S, Ruszczak Z, Schwartz RA. COVID-19: Topical agents and therapeutic prevention of nasal viral acquisition. Dermatol Ther 2021;34:e14454. [PMID: 33107144 DOI: 10.1111/dth.14454] [Reference Citation Analysis]
30 López Reboiro ML, Suárez Fuentetaja R, Gutiérrez López R, Ares Castro-Conde B, Sardiña González C, Navarro Menéndez I, Pereyra Barrionuevo MF, Alves Pérez MT, López Castro J. Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19. J Infect 2021;82:e27-8. [PMID: 33737115 DOI: 10.1016/j.jinf.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Udovicic I, Stanojevic I, Djordjevic D, Zeba S, Rondovic G, Abazovic T, Lazic S, Vojvodic D, To K, Abazovic D, Khan W, Surbatovic M. Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19. J Clin Med 2021;10:5815. [PMID: 34945111 DOI: 10.3390/jcm10245815] [Reference Citation Analysis]
32 Elbadry MI, Tawfeek A, Abdellatif MG, Salama EH, Abudeif A, Mahmoud H, Ezeldin M, Abdelkareem RM, Rashad UM. Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia. Br J Haematol 2021. [PMID: 34888860 DOI: 10.1111/bjh.17986] [Reference Citation Analysis]
33 Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, Wallner I, Marsden P, Dave S, Branley H, Russell G, Dharmarajah N, Kon OM. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med 2021;9:107-16. [PMID: 33217366 DOI: 10.1016/S2213-2600(20)30407-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
34 Ciurkiewicz M, Armando F, Schreiner T, de Buhr N, Pilchová V, Krupp-Buzimikic V, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W, Schulz C, Gerhauser I. Ferrets are valuable models for SARS-CoV-2 research. Vet Pathol 2022;:3009858211071012. [PMID: 35001763 DOI: 10.1177/03009858211071012] [Reference Citation Analysis]
35 Medetalibeyoglu A, Emet S, Kose M, Akpinar TS, Senkal N, Catma Y, Kaytaz AM, Genc S, Omer B, Tukek T. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study. Angiology 2021;72:187-93. [PMID: 32969233 DOI: 10.1177/0003319720961267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Li H, Huang H, Cui Y, Li W, Zhang S, Chen Y. Study on the Mechanism of Capillary Leakage Caused by Hypoxia-Inducible Factor-1α through Inducing High Expression of Matrix Metalloproteinase-9. J Oncol 2021;2021:9130650. [PMID: 34567119 DOI: 10.1155/2021/9130650] [Reference Citation Analysis]
37 Wang L, Astone M, Alam SK, Zhu Z, Pei W, Frank DA, Burgess SM, Hoeppner LH. Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability. bioRxiv 2020:2020. [PMID: 33140053 DOI: 10.1101/2020.10.27.358374] [Reference Citation Analysis]
38 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Reference Citation Analysis]
39 Coate KC, Cha J, Shrestha S, Wang W, Gonçalves LM, Almaça J, Kapp ME, Fasolino M, Morgan A, Dai C, Saunders DC, Bottino R, Aramandla R, Jenkins R, Stein R, Kaestner KH, Vahedi G, Consortium H, Brissova M, Powers AC. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells. bioRxiv 2020:2020. [PMID: 33106804 DOI: 10.1101/2020.08.31.275719] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 19.5] [Reference Citation Analysis]
40 Thwaites RS, Sanchez Sevilla Uruchurtu A, Siggins MK, Liew F, Russell CD, Moore SC, Fairfield C, Carter E, Abrams S, Short CE, Thaventhiran T, Bergstrom E, Gardener Z, Ascough S, Chiu C, Docherty AB, Hunt D, Crow YJ, Solomon T, Taylor GP, Turtle L, Harrison EM, Dunning J, Semple MG, Baillie JK, Openshaw PJ; ISARIC4C investigators. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol 2021;6:eabg9873. [PMID: 33692097 DOI: 10.1126/sciimmunol.abg9873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 29.0] [Reference Citation Analysis]
41 Perico L, Benigni A, Remuzzi G. Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic. Curr Opin Nephrol Hypertens 2021;30:252-63. [PMID: 33395036 DOI: 10.1097/MNH.0000000000000692] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 McCormick KD, Mellors JW, Jacobs JL. Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2. Curr Opin HIV AIDS 2021;16:3-10. [PMID: 33186228 DOI: 10.1097/COH.0000000000000656] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Richardson E, García-Bernal D, Calabretta E, Jara R, Palomo M, Baron RM, Yanik G, Fareed J, Vlodavsky I, Iacobelli M, Díaz-Ricart M, Richardson PG, Carlo-Stella C, Moraleda JM. Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes. Expert Opin Ther Targets 2021;:1-11. [PMID: 34167431 DOI: 10.1080/14728222.2021.1944101] [Reference Citation Analysis]
44 Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J Appl Physiol (1985) 2021;130:877-91. [PMID: 33444117 DOI: 10.1152/japplphysiol.00742.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
45 Golden JW, Cline CR, Zeng X, Garrison AR, Carey BD, Mucker EM, White LE, Shamblin JD, Brocato RL, Liu J, Babka AM, Rauch HB, Smith JM, Hollidge BS, Fitzpatrick C, Badger CV, Hooper JW. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 2020;5:142032. [PMID: 32841215 DOI: 10.1172/jci.insight.142032] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 33.5] [Reference Citation Analysis]
46 Maitz T, Parfianowicz D, Vojtek A, Rajeswaran Y, Vyas AV, Gupta R. COVID-19 Cardiovascular Connection: A Review of Cardiac Manifestations in COVID-19 Infection and Treatment Modalities. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101186] [Reference Citation Analysis]
47 Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
48 Oguz SH, Koca M, Yildiz BO. Aging versus youth: Endocrine aspects of vulnerability for COVID-19. Rev Endocr Metab Disord 2021. [PMID: 33860905 DOI: 10.1007/s11154-021-09656-y] [Reference Citation Analysis]
49 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
50 Beltrán-camacho L, Eslava-alcón S, Rojas-torres M, Sánchez-morillo D, Martinez-nicolás MP, Martín-bermejo V, de la Torre IG, Berrocoso E, Moreno JA, Moreno-luna R, Durán-ruiz MC. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00465-w] [Reference Citation Analysis]
51 Ma X, Guo S, Ruan S, Liu Y, Zang J, Yang Y, Dong H, Li Y, Ren T, An M, Li Y. HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy. ACS Appl Mater Interfaces. [DOI: 10.1021/acsami.1c19541] [Reference Citation Analysis]
52 Joffre J, Hellman J. Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation. Antioxid Redox Signal. 2021;. [PMID: 33637016 DOI: 10.1089/ars.2021.0027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Akella R, Raj R, Kannan L, Jacob A. Coexisting portal vein thrombosis and aortic thrombosis in a patient with COVID-19: A case report and literature review. IDCases 2022;28:e01509. [DOI: 10.1016/j.idcr.2022.e01509] [Reference Citation Analysis]
54 Schmidbauer ML, Ferse C, Salih F, Klingner C, Musleh R, Kunst S, Wittstock M, Neumann B, Schebesch K, Bösel J, Godau J, Lochner P, Adam EH, Jahnke K, Knier B, Schirotzek I, Müllges W, Notz Q, Dengl M, Güldner A, Onur OA, Garcia Borrega J, Dimitriadis K, Günther A; on behalf of the IGNITE Study Group. COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis. JCM 2022;11:605. [DOI: 10.3390/jcm11030605] [Reference Citation Analysis]
55 Pushin DM, Salikhova TY, Biryukova LS, Guria GT. Loss of Stability of the Blood Liquid State and Assessment of Shear-Induced Thrombosis Risk. Radiophys Quantum El 2021;63:804-25. [DOI: 10.1007/s11141-021-10097-5] [Reference Citation Analysis]
56 Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 2021. [PMID: 34373622 DOI: 10.1038/s41577-021-00588-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Hülsmann S, Khabbazzadeh S, Meissner K, Quintel M. A Potential Role of the Renin-Angiotensin-System for Disturbances of Respiratory Chemosensitivity in Acute Respiratory Distress Syndrome and Severe Acute Respiratory Syndrome. Front Physiol 2020;11:588248. [PMID: 33551831 DOI: 10.3389/fphys.2020.588248] [Reference Citation Analysis]
58 Declercq M, Treps L, Bousfia S, Carmeliet P, Witters P. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension. Eur Respir J 2021;58:2101645. [PMID: 34385264 DOI: 10.1183/13993003.01645-2021] [Reference Citation Analysis]
59 De Spiegeleer A, Bronselaer A, Teo JT, Byttebier G, De Tré G, Belmans L, Dobson R, Wynendaele E, Van De Wiele C, Vandaele F, Van Dijck D, Bean D, Fedson D, De Spiegeleer B. The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. J Am Med Dir Assoc 2020;21:909-914.e2. [PMID: 32674818 DOI: 10.1016/j.jamda.2020.06.018] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 37.5] [Reference Citation Analysis]
60 Dumas SJ, Meta E, Borri M, Luo Y, Li X, Rabelink TJ, Carmeliet P. Phenotypic diversity and metabolic specialization of renal endothelial cells. Nat Rev Nephrol 2021;17:441-64. [PMID: 33767431 DOI: 10.1038/s41581-021-00411-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
61 [DOI: 10.1101/2020.07.03.20145912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
62 Awasthi S, Wagner T, Venkatakrishnan AJ, Puranik A, Hurchik M, Agarwal V, Conrad I, Kirkup C, Arunachalam R, O'Horo J, Kremers W, Kashyap R, Morice W 2nd, Halamka J, Williams AW, Faubion WA Jr, Badley AD, Gores GJ, Soundararajan V. Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients. Cell Death Discov 2021;7:55. [PMID: 33723251 DOI: 10.1038/s41420-021-00429-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
63 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
64 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
65 Kamin Mukaz D, Gergi M, Koh I, Zakai NA, Judd SE, Sholzberg M, Baumann Kreuziger L, Freeman K, Colovos C, Olson NC, Cushman M. Thrombo‐inflammatory biomarkers and D‐dimer in a biracial cohort study. Res Pract Thromb Haemost 2021;5. [DOI: 10.1002/rth2.12632] [Reference Citation Analysis]
66 Barhoumi T, Alghanem B, Shaibah H, Mansour FA, Alamri HS, Akiel MA, Alroqi F, Boudjelal M. SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril). Front Immunol 2021;12:728896. [PMID: 34616396 DOI: 10.3389/fimmu.2021.728896] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Doevelaar AAN, Bachmann M, Hölzer B, Seibert FS, Rohn BJ, Bauer F, Witzke O, Dittmer U, Bachmann M, Yilmaz S, Dittmer R, Schneppenheim S, Babel N, Budde U, Westhoff TH. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019. Crit Care Med 2021;49:e512-20. [PMID: 33591004 DOI: 10.1097/CCM.0000000000004918] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
68 Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, Bulla R. COVID-19, Pre-Eclampsia, and Complement System. Front Immunol 2021;12:775168. [PMID: 34868042 DOI: 10.3389/fimmu.2021.775168] [Reference Citation Analysis]
69 [DOI: 10.1101/2020.05.11.088500] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
70 [DOI: 10.1101/2020.08.23.20177824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
71 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
72 Huang T, Sun L, Kang D, Poongavanam V, Liu X, Zhan P, Menéndez-Arias L. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses. Adv Exp Med Biol 2021;1322:219-60. [PMID: 34258743 DOI: 10.1007/978-981-16-0267-2_9] [Reference Citation Analysis]
73 Luban J, Sattler RA, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, Pykett M, Welch EM, O'Keefe K, Kong R, Goodwin E, Jacobson A, Paessler S, Peltz SW. The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines. Virus Res 2021;292:198246. [PMID: 33249060 DOI: 10.1016/j.virusres.2020.198246] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
74 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
75 Ismayl M, Butt DN, Balakrishna AM, Kousa O, Kabach A. COVID-19 presenting with myocardial infarction with nonobstructive coronary arteries. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2057158] [Reference Citation Analysis]
76 Chiumello D, Busana M, Coppola S, Romitti F, Formenti P, Bonifazi M, Pozzi T, Palumbo MM, Cressoni M, Herrmann P, Meissner K, Quintel M, Camporota L, Marini JJ, Gattinoni L. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med 2020;46:2187-96. [PMID: 33089348 DOI: 10.1007/s00134-020-06281-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 26.0] [Reference Citation Analysis]
77 Peng TJ, Jasne AS, Simonov M, Abdelhakim S, Kone G, Cheng YK, Rethana M, Tarasaria K, Herman AL, Baker AD, Yaghi S, Frontera JA, Sansing LH, Falcone GJ, Spudich S, Schindler J, Sheth KN, Sharma R. Prior Stroke and Age Predict Acute Ischemic Stroke Among Hospitalized COVID-19 Patients: A Derivation and Validation Study. Front Neurol 2021;12:741044. [PMID: 34675873 DOI: 10.3389/fneur.2021.741044] [Reference Citation Analysis]
78 Jud P, Gressenberger P, Muster V, Avian A, Meinitzer A, Strohmaier H, Sourij H, Raggam RB, Stradner MH, Demel U, Kessler HH, Eller K, Brodmann M. Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection-A Cross-Sectional Study. Front Cardiovasc Med 2021;8:750887. [PMID: 34722682 DOI: 10.3389/fcvm.2021.750887] [Reference Citation Analysis]
79 Tuuminen R, Hecht I, Kanclerz P. Age-related macular degeneration and mortality in SARS-CoV-2-infected patients. Acta Ophthalmol 2021;99:e969-70. [PMID: 33258211 DOI: 10.1111/aos.14685] [Reference Citation Analysis]
80 Sharma P, Ng JH, Bijol V, Jhaveri KD, Wanchoo R. Pathology of COVID-19-associated acute kidney injury. Clin Kidney J 2021;14:i30-9. [PMID: 33796284 DOI: 10.1093/ckj/sfab003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
81 Illian DN, Siregar ES, Sumaiyah S, Utomo AR, Nuryawan A, Basyuni M. Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets. Heliyon 2021;7:e06001. [PMID: 33532640 DOI: 10.1016/j.heliyon.2021.e06001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
82 Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol 2020;40:2586-97. [PMID: 32960072 DOI: 10.1161/ATVBAHA.120.314515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
83 von der Thüsen JH, van Bommel J, Kros JM, Verdijk RM, Lopuhaä B, Lam KH, Dik WA, Miedema JR. Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia. J Hematop 2020;:1-5. [PMID: 33110452 DOI: 10.1007/s12308-020-00423-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
84 Barbosa LC, Gonçalves TL, de Araujo LP, Rosario LVO, Ferrer VP. Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul Pharmacol 2021;137:106829. [PMID: 33422689 DOI: 10.1016/j.vph.2021.106829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
85 Bilgin E, Ertenli Aİ. Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: "Inflammatory Thrombosis with Immune Endotheliitis-ITIE". Rheumatol Int 2021;41:679-80. [PMID: 33388970 DOI: 10.1007/s00296-020-04768-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
86 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
87 Zhou T, Su TT, Mudianto T, Wang J. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J Exp Med 2020;217:e20200674. [PMID: 32910820 DOI: 10.1084/jem.20200674] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
88 Shrivastav A, Zhou WS, Ng S, Ding J, Gilada T, Chua CH, Dutt S, Natarajan S, Agrawal R. Choroidal Microvascular Alterations in COVID-19 Patients. Ocul Immunol Inflamm 2022;:1-6. [PMID: 35413220 DOI: 10.1080/09273948.2022.2062387] [Reference Citation Analysis]
89 Xu J, Liang Z, Jian W, Li J, Tang G, Mo X, Zhang D, Zheng J, Qian Y, Liu J, Li S. Changes of quantitative CT-based airway wall dimensions in patients with COVID-19 during early recovery. J Thorac Dis 2021;13:1517-30. [PMID: 33841944 DOI: 10.21037/jtd-20-2790] [Reference Citation Analysis]
90 Kalinskaya A, Dukhin O, Molodtsov I, Maltseva A, Sokorev D, Elizarova A, Sapozhnikova O, Glebova K, Stonogina D, Shakhidzhanov S, Nikonov E, Mazus A, Spiridonov I, Ataullakhanov F, Margolis L, Shpektor A, Vasilieva E. Dynamics of coagulopathy in patients with different COVID-19 severity. medRxiv 2020:2020. [PMID: 32637973 DOI: 10.1101/2020.07.02.20145284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Park KS, Schecterson L, Gumbiner BM. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin. Am J Physiol Heart Circ Physiol 2021;320:H1403-10. [PMID: 33577432 DOI: 10.1152/ajpheart.00002.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Herrero Y, Pascuali N, Velázquez C, Oubiña G, Hauk V, de Zúñiga I, Peña MG, Martínez G, Lavolpe M, Veiga F, Neuspiller F, Abramovich D, Scotti L, Parborell F. SARS-CoV-2 infection negatively affects ovarian function in ART patients. Biochim Biophys Acta Mol Basis Dis 2022;1868:166295. [PMID: 34718118 DOI: 10.1016/j.bbadis.2021.166295] [Reference Citation Analysis]
93 Yamaoka-Tojo M. Vascular Endothelial Glycocalyx Damage in COVID-19. Int J Mol Sci 2020;21:E9712. [PMID: 33352699 DOI: 10.3390/ijms21249712] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
94 Çakmak F, Demirbuga A, Demirkol D, Gümüş S, Torun SH, Kayaalp GK, Ömeroglu RE, Somer A, Uysalol M, Yıldız R, Ayaz NA. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc Res 2021;138:104196. [PMID: 34097919 DOI: 10.1016/j.mvr.2021.104196] [Reference Citation Analysis]
95 Akilesh S, Nast CC, Yamashita M, Henriksen K, Charu V, Troxell ML, Kambham N, Bracamonte E, Houghton D, Ahmed NI, Chong CC, Thajudeen B, Rehman S, Khoury F, Zuckerman JE, Gitomer J, Raguram PC, Mujeeb S, Schwarze U, Shannon MB, De Castro I, Alpers CE, Najafian B, Nicosia RF, Andeen NK, Smith KD. Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. Am J Kidney Dis 2021;77:82-93.e1. [PMID: 33045255 DOI: 10.1053/j.ajkd.2020.10.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 11.5] [Reference Citation Analysis]
96 Brancaccio G, Gussetti N, Sasset L, Alaibac M, Tarantello M, Salmaso R, Trevenzoli M, Cattelan AM. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions. Pathog Glob Health 2021;:1-4. [PMID: 33729097 DOI: 10.1080/20477724.2021.1901040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Lebeau G, Vagner D, Frumence É, Ah-Pine F, Guillot X, Nobécourt E, Raffray L, Gasque P. Deciphering SARS-CoV-2 Virologic and Immunologic Features. Int J Mol Sci 2020;21:E5932. [PMID: 32824753 DOI: 10.3390/ijms21165932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
98 Subramaniam S, Ogoti Y, Hernandez I, Zogg M, Botros F, Burns R, DeRousse JT, Dockendorff C, Mackman N, Antoniak S, Fletcher C, Weiler H. A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C). Blood Adv 2021;5:2760-74. [PMID: 34242391 DOI: 10.1182/bloodadvances.2021004360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 O'Brien ER, Sandhu JK. Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? Cell Stress Chaperones 2020;25:725-9. [PMID: 32761452 DOI: 10.1007/s12192-020-01146-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
100 Zayour M, Soukarieh K, Al Ashkar R, Almoussawi M, Nassereldine R, Atat R, Mansour B. Acute Cerebral Ischemic Infarct in a 34-Year-Old Patient After an Asymptomatic COVID-19 Infection: A Case Report. Cureus. [DOI: 10.7759/cureus.21507] [Reference Citation Analysis]
101 Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J Virol 2021;95:e0139621. [PMID: 34549987 DOI: 10.1128/JVI.01396-21] [Reference Citation Analysis]
102 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 García-Moncó JC, Cabrera-Muras A, Collía-Fernández A, Erburu-Iriarte M, Rodrigo-Armenteros P, Oyarzun-Irazu I, Martínez-Condor D, Bilbao-González A, Carmona-Abellán M, Caballero-Romero I, Gómez-Beldarrain M. Neurological reasons for consultation and hospitalization during the COVID-19 pandemic. Neurol Sci 2020;41:3031-8. [PMID: 32935157 DOI: 10.1007/s10072-020-04714-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
104 Martinez OM, Bridges ND, Goldmuntz E, Pascual V. The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges. Nat Med 2020;26:1819-24. [PMID: 33139949 DOI: 10.1038/s41591-020-1140-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
105 Browne S, Gill EL, Schultheiss P, Goswami I, Healy KE. Stem cell-based vascularization of microphysiological systems. Stem Cell Reports 2021:S2213-6711(21)00145-4. [PMID: 33836144 DOI: 10.1016/j.stemcr.2021.03.015] [Reference Citation Analysis]
106 Volpe N, Luca Schera GB, Dall'Asta A, Di Pasquo E, Ghi T. COVID-19 in pregnancy: where are we now? J Perinat Med 2021;49:637-42. [PMID: 34187136 DOI: 10.1515/jpm-2021-0309] [Reference Citation Analysis]
107 Soliman O, Moeen S, Abbas YA, Kamel EZ. The impact of dexamethasone versus methylprednisolone upon neutrophil/lymphocyte ratio in COVID-19 patients admitted to ICU and its implication upon mortality. Egyptian Journal of Anaesthesia 2022;38:78-84. [DOI: 10.1080/11101849.2021.2024985] [Reference Citation Analysis]
108 Kumar V. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? Int Rev Immunol 2021;40:72-107. [PMID: 33155525 DOI: 10.1080/08830185.2020.1840567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
109 Gaspar VP, Ibrahim S, Sobsey CA, Richard VR, Spatz A, Zahedi RP, Borchers CH. Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction Monitoring. ACS Pharmacol Transl Sci 2020;3:1304-9. [PMID: 33344903 DOI: 10.1021/acsptsci.0c00134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Alonso MN, Javier Jareño Esteban J, García-León N. [PULMONARY VASCULAR TONE DYSREGULATION AND MICROTHROMBOSIS IN COVID-19]. Arch Bronconeumol 2021. [PMID: 34054194 DOI: 10.1016/j.arbres.2021.05.007] [Reference Citation Analysis]
111 Savastano MC, Larici AR, Crincoli E, De Filippis A, Cicchetti G, Gambini G, Savastano A, Marano R, Natale L, Rizzo S. Retinal vascular impairment matched to the pulmonary damage in early post-COVID 19 patients. Eur J Ophthalmol 2022;:11206721221079153. [PMID: 35174719 DOI: 10.1177/11206721221079153] [Reference Citation Analysis]
112 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
113 Farhadian SF, Seilhean D, Spudich S. Neuropathogenesis of acute coronavirus disease 2019. Curr Opin Neurol 2021;34:417-22. [PMID: 33852526 DOI: 10.1097/WCO.0000000000000944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Goyal R, Bala R, Sindhu RK, Zehravi M, Madaan R, Ramproshad S, Mondal B, Dey A, Rahman MH, Cavalu S. Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2. Nanomaterials 2022;12:1530. [DOI: 10.3390/nano12091530] [Reference Citation Analysis]
115 Singh U, Hernandez KM, Aronow BJ, Wurtele ES. African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci Rep 2021;11:9905. [PMID: 33972602 DOI: 10.1038/s41598-021-89224-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Ranasinghe RNK, Taylor DR, Mazaheri T, Al-Hasani W, Buchanan D, Rao N, Vincent RP. Cardiac markers in Black, Asian and minority ethnic (BAME) patients with COVID-19. J Clin Pathol 2020:jclinpath-2020-207188. [PMID: 33303528 DOI: 10.1136/jclinpath-2020-207188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Carneiro JDA, Ramos GF, de Carvalho WB, Johnston C, Delgado AF. Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2. Clinics (Sao Paulo) 2020;75:e2252. [PMID: 33331400 DOI: 10.6061/clinics/2020/e2252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Amaral-Machado L, Oliveira WN, Rodrigues VM, Albuquerque NA, Alencar ÉN, Egito EST. Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients? Biomed Pharmacother 2021;134:111143. [PMID: 33360048 DOI: 10.1016/j.biopha.2020.111143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, Kühn J, Braune S, Göbel U, Thölking G, Gröschel A, Pavenstädt H, Vink H, Kümpers P. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis 2021;24:145-57. [PMID: 33058027 DOI: 10.1007/s10456-020-09753-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
120 Kosmopoulos A, Bhatt DL, Meglis G, Verma R, Pan Y, Quan A, Teoh H, Verma M, Jiao L, Wang R, Juliano RA, Kajil M, Kosiborod MN, Bari B, Berih AA, Aguilar M, Escano A, Leung A, Coelho I, Hibino M, Díaz R, Mason RP, Steg PG, Simon T, Go AS, Ambrosy AP, Choi R, Kushner AM, Leiter LA, Al-Omran M, Verma S, Mazer CD. A randomized trial of icosapent ethyl in ambulatory patients with COVID-19. iScience 2021;24:103040. [PMID: 34462732 DOI: 10.1016/j.isci.2021.103040] [Reference Citation Analysis]
121 Huang Y, Ling Q, Manyande A, Wu D, Xiang B. Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review. Front Neurosci 2022;16:855868. [DOI: 10.3389/fnins.2022.855868] [Reference Citation Analysis]
122 Xue M, Zeng Y, Qu HQ, Zhang T, Li N, Huang H, Zheng P, Hu H, Zhou L, Duan Z, Zhang Y, Bao W, Tian LF, Hakonarson H, Zhong N, Zhang XD, Sun B. Heparin-binding protein levels correlate with aggravation and multiorgan damage in severe COVID-19. ERJ Open Res 2021;7:00741-2020. [PMID: 33564671 DOI: 10.1183/23120541.00741-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
123 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
124 Byttebier G, Belmans L, Alexander M, Saxberg BEH, De Spiegeleer B, De Spiegeleer A, Devreker N, Van Praet JT, Vanhove K, Reybrouck R, Wynendaele E, Fedson DS. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Hum Vaccin Immunother 2021;17:2841-50. [PMID: 34047686 DOI: 10.1080/21645515.2021.1920271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Karam DP. Better Anticoagulated Than Not! Hypercoagulability in COVID-19. JCO Oncol Pract 2021;17:522-3. [PMID: 34133217 DOI: 10.1200/OP.21.00359] [Reference Citation Analysis]
126 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Payton JI, Wong S, Lombana NF, Saint-Cyr MS, Altman AM, Brooke SM. Microsurgery in the era of COVID-19. Proc (Bayl Univ Med Cent) 2021;34:269-73. [PMID: 33678960 DOI: 10.1080/08998280.2020.1864982] [Reference Citation Analysis]
128 Makhoul K, Shukha Y, Hanna LA, Nitecki S, Leiderman M, Hayek T, Hamoud S. A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19. Int J Infect Dis 2021;106:401-4. [PMID: 33862207 DOI: 10.1016/j.ijid.2021.04.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Englert H, Rangaswamy C, Deppermann C, Sperhake JP, Krisp C, Schreier D, Gordon E, Konrath S, Haddad M, Pula G, Mailer RK, Schlüter H, Kluge S, Langer F, Püschel K, Panousis K, Stavrou EX, Maas C, Renné T, Frye M. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 2021;67:103382. [PMID: 34000623 DOI: 10.1016/j.ebiom.2021.103382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
130 Naidu SA, Clemens RA, Naidu AS. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control. Journal of Dietary Supplements. [DOI: 10.1080/19390211.2022.2075072] [Reference Citation Analysis]
131 Schiaffino S, Giacomazzi F, Esseridou A, Cozzi A, Carriero S, Mazzaccaro DP, Nano G, Di Leo G, Spagnolo P, Sardanelli F. Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis. Medicine (Baltimore) 2021;100:e24002. [PMID: 33429763 DOI: 10.1097/MD.0000000000024002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 Tilliridou V, Kirkbride R, Dickinson R, Tiernan J, Yong GL, van Beek EJ, Murchison JT, Williams MC. Pulmonary embolism severity before and during the COVID-19 pandemic. Br J Radiol 2021;94:20210264. [PMID: 34106780 DOI: 10.1259/bjr.20210264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 O'Kennedy N, Duttaroy AK. Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime? Med Hypotheses 2021;147:110480. [PMID: 33421690 DOI: 10.1016/j.mehy.2020.110480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Dixon L, Coughlan C, Karunaratne K, Gorgoraptis N, Varley J, Husselbee J, Mallon D, Carroll R, Jones B, Boynton C, Pritchard J, Youngstein T, Mason J, Gabriel C. Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology. J Neurol Neurosurg Psychiatry 2020:jnnp-2020-324291. [PMID: 32855293 DOI: 10.1136/jnnp-2020-324291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
135 Rochette L, Ghibu S. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. Int J Mol Sci 2021;22:7979. [PMID: 34360751 DOI: 10.3390/ijms22157979] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
136 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Reference Citation Analysis]
138 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
139 Gregoriano C, Molitor A, Haag E, Kutz A, Koch D, Haubitz S, Conen A, Bernasconi L, Hammerer-Lercher A, Fux CA, Mueller B, Schuetz P. Activation of Vasopressin System During COVID-19 is Associated With Adverse Clinical Outcomes: An Observational Study. J Endocr Soc 2021;5:bvab045. [PMID: 34056499 DOI: 10.1210/jendso/bvab045] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
140 Rhally A, Griffa A, Kremer S, Uginet M, Breville G, Stancu P, Assal F, Lalive PH, Lövblad KO, Allali G. C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy. J Neural Transm (Vienna) 2021;128:1899-906. [PMID: 34709472 DOI: 10.1007/s00702-021-02429-6] [Reference Citation Analysis]
141 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
142 Muhl L, He L, Sun Y, Andaloussi Mäe M, Pietilä R, Liu J, Genové G, Zhang L, Xie Y, Leptidis S, Mocci G, Stritt S, Osman A, Anisimov A, Hemanthakumar KA, Räsänen M, Hansson EM, Björkegren J, Vanlandewijck M, Blomgren K, Mäkinen T, Peng XR, Hu Y, Ernfors P, Arnold TD, Alitalo K, Lendahl U, Betsholtz C. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Reports 2022:S2213-6711(22)00149-7. [PMID: 35452595 DOI: 10.1016/j.stemcr.2022.03.016] [Reference Citation Analysis]
143 Hekman RM, Hume AJ, Goel RK, Abo KM, Huang J, Blum BC, Werder RB, Suder EL, Paul I, Phanse S, Youssef A, Alysandratos KD, Padhorny D, Ojha S, Mora-Martin A, Kretov D, Ash PEA, Verma M, Zhao J, Patten JJ, Villacorta-Martin C, Bolzan D, Perea-Resa C, Bullitt E, Hinds A, Tilston-Lunel A, Varelas X, Farhangmehr S, Braunschweig U, Kwan JH, McComb M, Basu A, Saeed M, Perissi V, Burks EJ, Layne MD, Connor JH, Davey R, Cheng JX, Wolozin BL, Blencowe BJ, Wuchty S, Lyons SM, Kozakov D, Cifuentes D, Blower M, Kotton DN, Wilson AA, Mühlberger E, Emili A. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell 2020;80:1104-1122.e9. [PMID: 33259812 DOI: 10.1016/j.molcel.2020.11.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
144 Basra R, Whyte M, Karalliedde J, Vas P. What is the impact of microvascular complications of diabetes on severe COVID-19? Microvasc Res 2021;140:104310. [PMID: 34979154 DOI: 10.1016/j.mvr.2021.104310] [Reference Citation Analysis]
145 Engin AB, Engin ED, Engin A. Current opinion in neurological manifestations of SARS-CoV-2 infection. Curr Opin Toxicol 2021;25:49-56. [PMID: 33817451 DOI: 10.1016/j.cotox.2021.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
146 Perico L, Morigi M, Galbusera M, Pezzotta A, Gastoldi S, Imberti B, Perna A, Ruggenenti P, Donadelli R, Benigni A, Remuzzi G. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation. Front Immunol 2022;13:827146. [DOI: 10.3389/fimmu.2022.827146] [Reference Citation Analysis]
147 Castro P, Palomo M, Moreno-Castaño AB, Fernández S, Torramadé-Moix S, Pascual G, Martinez-Sanchez J, Richardson E, Téllez A, Nicolas JM, Carreras E, Richardson PG, Badimon JJ, Escolar G, Diaz-Ricart M. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc Drugs Ther 2021. [PMID: 34097193 DOI: 10.1007/s10557-021-07207-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
148 Batra N, De Souza C, Batra J, Raetz AG, Yu AM. The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19). Int J Mol Sci 2020;21:E6412. [PMID: 32899231 DOI: 10.3390/ijms21176412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
149 Banderas García S, Aragón D, Azarfane B, Trejo F, Garrell-Salat X, Sánchez-Montalvá A, Otero-Romero S, Garcia-Arumi J, Zapata MA. Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease. BMJ Open Ophthalmol 2022;7:e000867. [PMID: 35039796 DOI: 10.1136/bmjophth-2021-000867] [Reference Citation Analysis]
150 Mosleh W, Chen K, Pfau SE, Vashist A. Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes. J Clin Med 2020;9:E1862. [PMID: 32549229 DOI: 10.3390/jcm9061862] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
151 Battinelli EM. COVID-19 concerns aggregate around platelets. Blood 2020;136:1221-3. [PMID: 32957116 DOI: 10.1182/blood.2020007805] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
152 Shaath H, Vishnubalaji R, Elkord E, Alajez NM. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19. Cells. 2020;9. [PMID: 33138195 DOI: 10.3390/cells9112374] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
153 Fernández S, Palomo M, Molina P, Díaz-Ricart M, Escolar G, Téllez A, Seguí F, Ventosa H, Torramade-Moix S, Rovira M, Carreras E, Nicolás JM, Castro P. Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender. J Thromb Haemost 2021;19:1948-58. [PMID: 33872468 DOI: 10.1111/jth.15343] [Reference Citation Analysis]
154 Sozio E, Tascini C, Fabris M, D'Aurizio F, De Carlo C, Graziano E, Bassi F, Sbrana F, Ripoli A, Pagotto A, Giacinta A, Gerussi V, Visentini D, De Stefanis P, Merelli M, Saeed K, Curcio F. MR-proADM as prognostic factor of outcome in COVID-19 patients. Sci Rep 2021;11:5121. [PMID: 33664308 DOI: 10.1038/s41598-021-84478-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
155 Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK, Markram H. A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. Front Public Health 2021;9:695139. [PMID: 34395368 DOI: 10.3389/fpubh.2021.695139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Ali Awan H, Najmuddin Diwan M, Aamir A, Ali M, Di Giannantonio M, Ullah I, Shoib S, De Berardis D. SARS-CoV-2 and the Brain: What Do We Know about the Causality of 'Cognitive COVID? J Clin Med 2021;10:3441. [PMID: 34362224 DOI: 10.3390/jcm10153441] [Reference Citation Analysis]
157 Mescoli A, Maffei G, Pillo G, Bortone G, Marchesi S, Morandi E, Ranzi A, Rotondo F, Serra S, Vaccari M, Zauli Sajani S, Mascolo MG, Jacobs MN, Colacci A. The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation. Front Genet 2020;11:579964. [PMID: 33240326 DOI: 10.3389/fgene.2020.579964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
158 Ochoa-Callejero L, García-Sanmartín J, Villoslada-Blanco P, Íñiguez M, Pérez-Matute P, Pujadas E, Fowkes ME, Brody R, Oteo JA, Martínez A. Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients. J Endocr Soc 2021;5:bvaa199. [PMID: 33506161 DOI: 10.1210/jendso/bvaa199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
159 Krämer A, Billaud JN, Tugendreich S, Shiffman D, Jones M, Green J. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function. BMC Bioinformatics 2021;22:229. [PMID: 33941085 DOI: 10.1186/s12859-021-04148-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Butsabong T, Felippe M, Campagnolo P, Maringer K. The emerging role of perivascular cells (pericytes) in viral pathogenesis. J Gen Virol 2021;102. [PMID: 34424156 DOI: 10.1099/jgv.0.001634] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Crisan-Dabija R, Pavel CA, Popa IV, Tarus A, Burlacu A. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19. J Proteome Res 2020;19:4327-38. [PMID: 32883081 DOI: 10.1021/acs.jproteome.0c00387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
162 Zacharowski K; Studiengruppe FX06-COVID. [FX06-COVID: Improvement of arterial oxygenation in intensive care patients with a severe course of COVID-19]. Anaesthesist 2021;70:71-2. [PMID: 33001237 DOI: 10.1007/s00101-020-00862-y] [Reference Citation Analysis]
163 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
164 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319-29. [PMID: 33824483 DOI: 10.1038/s41577-021-00536-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 33.0] [Reference Citation Analysis]
165 Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. J Am Acad Dermatol. 2020;83:1704-1716. [PMID: 32891785 DOI: 10.1016/j.jaad.2020.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
166 Fahmy OH, Daas FM, Salunkhe V, Petrey JL, Cosar EF, Ramirez J, Akca O. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit Care Explor 2021;3:e0427. [PMID: 34036278 DOI: 10.1097/CCE.0000000000000427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Zhou Y, Qian X, Liu Z, Yang H, Liu T, Chen K, Wang Y, Sham PC, Yu Y, Li MJ. Coagulation factors and the incidence of COVID-19 severity: Mendelian randomization analyses and supporting evidence. Signal Transduct Target Ther 2021;6:222. [PMID: 34099622 DOI: 10.1038/s41392-021-00640-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
168 Funk CD, Ardakani A. A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes. Front Pharmacol 2020;11:1214. [PMID: 32848802 DOI: 10.3389/fphar.2020.01214] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
169 Li C, Zhao H, Cheng L, Wang B. Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19. Drug Des Devel Ther 2021;15:1345-56. [PMID: 33824579 DOI: 10.2147/DDDT.S301173] [Reference Citation Analysis]
170 Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
171 Wazny V, Siau A, Wu KX, Cheung C. Vascular underpinning of COVID-19. Open Biol 2020;10:200208. [PMID: 32847471 DOI: 10.1098/rsob.200208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
172 Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther 2020;12:170. [PMID: 33380345 DOI: 10.1186/s13195-020-00744-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
173 Ciaffi J, Meliconi R, Ruscitti P, Iagnocco A, Ferri C, Giacomelli R, Ursini F. Isolated "puffy hands" following COVID-19: clue to a long-term capillary leakage syndrome? Clin Rheumatol 2021;40:3863-4. [PMID: 34170445 DOI: 10.1007/s10067-021-05835-z] [Reference Citation Analysis]
174 Bime C, Casanova NG, Nikolich-Zugich J, Knox KS, Camp SM, Garcia JGN. Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury. Transl Res 2021;232:37-48. [PMID: 33358868 DOI: 10.1016/j.trsl.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Ismail Z, Salabei JK, Stanger G, Asnake ZT, Frimer L, Smock A. Third-Degree Heart Block Associated With Saddle Pulmonary Embolism: A Rare Sequelae of COVID-19-Induced Hypercoagulable State. Cureus 2021;13:e16246. [PMID: 34381643 DOI: 10.7759/cureus.16246] [Reference Citation Analysis]
176 Ruhl L, Pink I, Kühne JF, Beushausen K, Keil J, Christoph S, Sauer A, Boblitz L, Schmidt J, David S, Jäck HM, Roth E, Cornberg M, Schulz TF, Welte T, Höper MM, Falk CS. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal Transduct Target Ther 2021;6:418. [PMID: 34893580 DOI: 10.1038/s41392-021-00819-6] [Reference Citation Analysis]
177 Galán M, Jiménez-Altayó F. Small Resistance Artery Disease and ACE2 in Hypertension: A New Paradigm in the Context of COVID-19. Front Cardiovasc Med 2020;7:588692. [PMID: 33195477 DOI: 10.3389/fcvm.2020.588692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight 2021;6:148980. [PMID: 34061779 DOI: 10.1172/jci.insight.148980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Li J, Liu B. The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy. Cytokine Growth Factor Rev 2021;58:75-81. [PMID: 33558131 DOI: 10.1016/j.cytogfr.2020.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
180 Vechi HT, Maia LR, Alves MDM. Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series. Rev Inst Med Trop Sao Paulo 2020;62:e63. [PMID: 32901760 DOI: 10.1590/S1678-9946202062063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
181 Rafiee MJ, Babaki Fard F, Friedrich MG. COVID-19, myocardial edema and dexamethasone. Med Hypotheses 2020;145:110307. [PMID: 33035967 DOI: 10.1016/j.mehy.2020.110307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
182 Kawazoe M, Kihara M, Nanki T. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists. Pharmaceuticals (Basel) 2021;14:1256. [PMID: 34959657 DOI: 10.3390/ph14121256] [Reference Citation Analysis]
183 Burkhard-Koren NM, Haberecker M, Maccio U, Ruschitzka F, Schuepbach RA, Zinkernagel AS, Hardmeier T, Varga Z, Moch H. Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019. J Pathol Clin Res 2021;7:135-43. [PMID: 33185036 DOI: 10.1002/cjp2.189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
184 Martin-Cardona A, Lloreta Trull J, Albero-González R, Paraira Beser M, Andújar X, Ruiz-Ramirez P, Tur-Martínez J, Ferrer C, De Marcos Izquierdo JA, Pérez-Madrigal A, Goiburú González L, Espinós Perez J, Esteve M. SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports. BMC Gastroenterol 2021;21:334. [PMID: 34445965 DOI: 10.1186/s12876-021-01905-3] [Reference Citation Analysis]
185 Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 2021;63:103182. [PMID: 33422990 DOI: 10.1016/j.ebiom.2020.103182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
186 [DOI: 10.1101/2020.07.23.208041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
187 Mezoh G, Crowther NJ. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection. Adv Exp Med Biol 2021;1321:33-43. [PMID: 33656711 DOI: 10.1007/978-3-030-59261-5_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Chern A, Selesnick SH. Dissemination of Information During Public Health Crises: Early COVID-19 Data From The Laryngoscope. Laryngoscope 2020;130:2508-15. [PMID: 32964454 DOI: 10.1002/lary.29147] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Adugna DG. Current Clinical Application of Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients: Review. Stem Cells Cloning 2021;14:71-80. [PMID: 34785907 DOI: 10.2147/SCCAA.S333800] [Reference Citation Analysis]
190 Gaddh M, Maier CL. Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center. JCO Oncol Pract 2021;:OP2001056. [PMID: 34019440 DOI: 10.1200/OP.20.01056] [Reference Citation Analysis]
191 Pepe G, Guarracino A, Ballesio F, Parca L, Ausiello G, Helmer-citterich M. Evaluation of potential sponge effects of SARS genomes in human. Non-coding RNA Research 2022. [DOI: 10.1016/j.ncrna.2022.01.003] [Reference Citation Analysis]
192 Tan L, Lin ZC, Ray J, Wesselingh R, Oxley TJ, McFadyen J, Kapoor M, Hutton E. Neurological implications of COVID-19: a review of the science and clinical guidance. BMJ Neurol Open 2020;2:e000101. [PMID: 33681805 DOI: 10.1136/bmjno-2020-000101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
193 Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A. SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm. J Clin Med 2021;10:1064. [PMID: 33806540 DOI: 10.3390/jcm10051064] [Reference Citation Analysis]
194 Kuriakose J, Montezano AC, Touyz RM. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond) 2021;135:387-407. [PMID: 33511992 DOI: 10.1042/CS20200480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
195 Negri EM, Piloto BM, Morinaga LK, Jardim CVP, Lamy SAE, Ferreira MA, D'Amico EA, Deheinzelin D. Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series. Front Physiol 2020;11:573044. [PMID: 33192569 DOI: 10.3389/fphys.2020.573044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
196 Grieb P, Swiatkiewicz M, Prus K, Rejdak K. Hypoxia may be a determinative factor in COVID-19 progression. Curr Res Pharmacol Drug Discov 2021;2:100030. [PMID: 34870146 DOI: 10.1016/j.crphar.2021.100030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
197 Roshdy A, Zaher S, Fayed H, Coghlan JG. COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies. Front Cardiovasc Med 2020;7:626975. [PMID: 33585586 DOI: 10.3389/fcvm.2020.626975] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
198 Thacker VV, Sharma K, Dhar N, Mancini GF, Sordet-Dessimoz J, McKinney JD. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model. EMBO Rep 2021;22:e52744. [PMID: 33908688 DOI: 10.15252/embr.202152744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
199 Chakraborty U, Hati A, Chandra A. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication. Diabetes Metab Syndr 2021;15:102326. [PMID: 34731822 DOI: 10.1016/j.dsx.2021.102326] [Reference Citation Analysis]
200 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
201 Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, Zhang Y, Yin Q, Cho Y, Andrade L, Shadel GS, Hepokoski M, Lei T, Wang H, Zhang J, Yuan JX, Malhotra A, Manor U, Wang S, Yuan ZY, Shyy JY. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circ Res 2021;128:1323-6. [PMID: 33784827 DOI: 10.1161/CIRCRESAHA.121.318902] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 22.0] [Reference Citation Analysis]
202 Galea M, Agius M, Vassallo N. Neurological manifestations and pathogenic mechanisms of COVID-19. Neurol Res 2022;:1-12. [PMID: 34986754 DOI: 10.1080/01616412.2021.2024732] [Reference Citation Analysis]
203 Gross-Cohen M, Feld S, Arvatz G, Ilan N, Vlodavsky I. Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2. Front Oncol 2020;10:627463. [PMID: 33585253 DOI: 10.3389/fonc.2020.627463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Shirazi J, Donzanti MJ, Nelson KM, Zurakowski R, Fromen CA, Gleghorn JP. Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression. Cell Mol Bioeng 2020;:1-26. [PMID: 32837585 DOI: 10.1007/s12195-020-00637-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
205 Cialoni D, Brizzolari A, Samaja M, Bosco G, Paganini M, Pieri M, Lancellotti V, Marroni A. Nitric Oxide and Oxidative Stress Changes at Depth in Breath-Hold Diving. Front Physiol 2020;11:609642. [PMID: 33488400 DOI: 10.3389/fphys.2020.609642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
206 Stefely JA, Christensen BB, Gogakos T, Cone Sullivan JK, Montgomery GG, Barranco JP, Van Cott EM. Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism. Am J Hematol 2020;95:1522-30. [PMID: 32833259 DOI: 10.1002/ajh.25979] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
207 Ambrosino P, Molino A, Calcaterra I, Formisano R, Stufano S, Spedicato GA, Motta A, Papa A, Di Minno MND, Maniscalco M. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation. Biomedicines 2021;9:614. [PMID: 34071308 DOI: 10.3390/biomedicines9060614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Bhatraju PK, Morrell ED, Zelnick L, Sathe NA, Chai XY, Sakr SS, Sahi SK, Sader A, Lum DM, Liu T, Koetje N, Garay A, Barnes E, Lawson J, Cromer G, Bray MK, Pipavath S, Kestenbaum BR, Liles WC, Fink SL, West TE, Evans L, Mikacenic C, Wurfel MM. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study. Crit Care 2021;25:148. [PMID: 33874973 DOI: 10.1186/s13054-021-03547-z] [Reference Citation Analysis]
209 Higashikuni Y, Liu W, Obana T, Sata M. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications. Int J Mol Sci 2021;22:12081. [PMID: 34769508 DOI: 10.3390/ijms222112081] [Reference Citation Analysis]
210 Wilczynski SA, Wenceslau CF, McCarthy CG, Webb RC. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19? Am J Hypertens 2021;34:304-6. [PMID: 33877321 DOI: 10.1093/ajh/hpaa217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
211 Constant O, Barthelemy J, Bolloré K, Tuaillon E, Gosselet F, Chable-Bessia C, Merida P, Muriaux D, Van de Perre P, Salinas S, Simonin Y. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Front Immunol 2021;12:697329. [PMID: 34386007 DOI: 10.3389/fimmu.2021.697329] [Reference Citation Analysis]
212 Lawal IO, Kgatle MM, Mokoala K, Farate A, Sathekge MM. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2. BMC Cardiovasc Disord 2022;22:93. [PMID: 35264107 DOI: 10.1186/s12872-022-02534-8] [Reference Citation Analysis]
213 Annane D. Corticosteroids for COVID-19. Journal of Intensive Medicine 2021;1:14-25. [DOI: 10.1016/j.jointm.2021.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
214 Gorog DA, Storey RF, Gurbel PA, Tantry US, Berger JS, Chan MY, Duerschmied D, Smyth SS, Parker WAE, Ajjan RA, Vilahur G, Badimon L, Berg JMT, Cate HT, Peyvandi F, Wang TT, Becker RC. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol 2022. [PMID: 35027697 DOI: 10.1038/s41569-021-00665-7] [Reference Citation Analysis]
215 Saggam A, Limgaokar K, Borse S, Chavan-Gautam P, Dixit S, Tillu G, Patwardhan B. Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management. Front Pharmacol 2021;12:623795. [PMID: 34012390 DOI: 10.3389/fphar.2021.623795] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
216 Villalba N, Baby S, Yuan SY. The Endothelial Glycocalyx as a Double-Edged Sword in Microvascular Homeostasis and Pathogenesis. Front Cell Dev Biol 2021;9:711003. [PMID: 34336864 DOI: 10.3389/fcell.2021.711003] [Reference Citation Analysis]
217 Kim J, Mukherjee A, Nelson D, Jozic A, Sahay G. Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32743574 DOI: 10.1101/2020.07.24.205583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
218 Parra-Izquierdo I, Aslan JE. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2020;46:826-30. [PMID: 32882716 DOI: 10.1055/s-0040-1715093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
219 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
220 Dutta S, Mukherjee A, Nongthomba U. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. Cytokine Growth Factor Rev 2022:S1359-6101(22)00002-8. [PMID: 35039221 DOI: 10.1016/j.cytogfr.2022.01.002] [Reference Citation Analysis]
221 Tiwari NR, Phatak S, Sharma VR, Agarwal SK. COVID-19 and thrombotic microangiopathies. Thromb Res 2021;202:191-8. [PMID: 33894421 DOI: 10.1016/j.thromres.2021.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
222 Ripon MAR, Bhowmik DR, Amin MT, Hossain MS. Role of arachidonic cascade in COVID-19 infection: A review. Prostaglandins Other Lipid Mediat 2021;154:106539. [PMID: 33592322 DOI: 10.1016/j.prostaglandins.2021.106539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
223 Dirican A, Ildir S, Uzar T, Karaman I, Ozkaya S. The role of endotheliitis in COVID-19: Real-world experience of 11 190 patients and literature review for a pathophysiological map to clinical categorisation. Int J Clin Pract 2021;75:e14843. [PMID: 34519155 DOI: 10.1111/ijcp.14843] [Reference Citation Analysis]
224 Vigário LC, Muradas G, Paiva C, Medei E. The Role of the Immune System on the Cardiac Complications Observed in SARS-CoV-2. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200266] [Reference Citation Analysis]
225 Gao Y, Galis ZS. Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and Disease. Arterioscler Thromb Vasc Biol 2021;41:179-85. [PMID: 33086867 DOI: 10.1161/ATVBAHA.120.314346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
226 Luo W, Li YX, Jiang LJ, Chen Q, Wang T, Ye DW. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19. Trends Pharmacol Sci 2020;41:531-43. [PMID: 32580895 DOI: 10.1016/j.tips.2020.06.007] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 44.5] [Reference Citation Analysis]
227 Zanza C, Racca F, Longhitano Y, Piccioni A, Franceschi F, Artico M, Abenavoli L, Maiese A, Passaro G, Volonnino G, La Russa R. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection. Int J Environ Res Public Health 2021;18:1268. [PMID: 33572570 DOI: 10.3390/ijerph18031268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
228 Pathangey G, Fadadu PP, Hospodar AR, Abbas AE. Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies. Am J Physiol Lung Cell Mol Physiol 2021;320:L301-30. [PMID: 33237815 DOI: 10.1152/ajplung.00259.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
229 Calles A, Aparicio MI, Alva M, Bringas M, Gutierrez N, Soto J, Arregui M, Tirado VC, Álvarez EL, Del Monte-Millán M, Massarrah T, Galera M, Álvarez R, Martín M. Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid. Front Oncol 2020;10:1777. [PMID: 33042826 DOI: 10.3389/fonc.2020.01777] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
230 Wastnedge EAN, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, Critchley HOD. Pregnancy and COVID-19. Physiol Rev 2021;101:303-18. [PMID: 32969772 DOI: 10.1152/physrev.00024.2020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 26.5] [Reference Citation Analysis]
231 Meyer AA, Mathews EH, Gous AGS, Mathews MJ. Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications. Front Cardiovasc Med 2022;9:737592. [DOI: 10.3389/fcvm.2022.737592] [Reference Citation Analysis]
232 Chioh FW, Fong SW, Young BE, Wu KX, Siau A, Krishnan S, Chan YH, Carissimo G, Teo LL, Gao F, Tan RS, Zhong L, Koh AS, Tan SY, Tambyah PA, Renia L, Ng LF, Lye DC, Cheung C. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife 2021;10:e64909. [PMID: 33752798 DOI: 10.7554/eLife.64909] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
233 Shen J, Hou Y, Zhou Y, Mehra R, Jehi L, Cheng F. The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and a Network Medicine Observation. Front Neurosci 2021;15:606926. [PMID: 33732102 DOI: 10.3389/fnins.2021.606926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
234 Stenmark KR, Frid MG, Gerasimovskaya E, Zhang H, McCarthy MK, Thurman JM, Morrison TE. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement. Pulm Circ 2021;11:20458940211015799. [PMID: 34046161 DOI: 10.1177/20458940211015799] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
235 Fignani D, Licata G, Brusco N, Nigi L, Grieco GE, Marselli L, Overbergh L, Gysemans C, Colli ML, Marchetti P, Mathieu C, Eizirik DL, Sebastiani G, Dotta F. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. Front Endocrinol (Lausanne) 2020;11:596898. [PMID: 33281748 DOI: 10.3389/fendo.2020.596898] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 19.5] [Reference Citation Analysis]
236 Hattori Y, Hattori K, Machida T, Matsuda N. Vascular endotheliitis associated with infections: its pathogenetic role and therapeutic implication. Biochem Pharmacol 2022;:114909. [PMID: 35021044 DOI: 10.1016/j.bcp.2022.114909] [Reference Citation Analysis]
237 Guan SP, Seet RCS, Kennedy BK. Does eNOS derived nitric oxide protect the young from severe COVID-19 complications? Ageing Res Rev 2020;64:101201. [PMID: 33157320 DOI: 10.1016/j.arr.2020.101201] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
238 Ionescu M, Stoian AP, Rizzo M, Serban D, Nuzzo D, Mazilu L, Suceveanu AI, Dascalu AM, Parepa IR. The Role of Endothelium in COVID-19. Int J Mol Sci 2021;22:11920. [PMID: 34769350 DOI: 10.3390/ijms222111920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, D'Angelo A, Steidler S, Galli L, Poli A, Fominskiy E, Calabrò MG, Colombo S, Monti G, Nicoletti R, Esposito A, Conte C, Dagna L, Ambrosio A, Scarpellini P, Ripa M, Spessot M, Carlucci M, Montorfano M, Agricola E, Baccellieri D, Bosi E, Tresoldi M, Castagna A, Martino G, Zangrillo A. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00013-6. [PMID: 33518461 DOI: 10.1053/j.jvca.2021.01.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
240 Mayerhöfer T, Perschinka F, Joannidis M. [Acute kidney injury and COVID-19: lung-kidney crosstalk during severe inflammation]. Med Klin Intensivmed Notfmed 2022. [PMID: 35476144 DOI: 10.1007/s00063-022-00919-3] [Reference Citation Analysis]
241 Sharp GC, Fraser A, Sawyer G, Kountourides G, Easey KE, Ford G, Olszewska Z, Howe LD, Lawlor DA, Alvergne A, Maybin JA. The COVID-19 pandemic and the menstrual cycle: research gaps and opportunities. Int J Epidemiol 2021:dyab239. [PMID: 34865021 DOI: 10.1093/ije/dyab239] [Reference Citation Analysis]
242 Marsh AG, Anderson GM, Izdepski EJ. Rapid COVID-19 Prognostic Blood Test for Disease Severity Using Epigenetic Immune System Biomarkers. Dela J Public Health 2020;6:26-9. [PMID: 34467104 DOI: 10.32481/djph.2020.07.08] [Reference Citation Analysis]
243 Kleen TO, Galdon AA, MacDonald AS, Dalgleish AG. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends". Front Immunol 2020;11:2059. [PMID: 33013871 DOI: 10.3389/fimmu.2020.02059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
244 Gladka MM, Maack C. The endothelium as Achilles' heel in COVID-19 patients. Cardiovasc Res 2020;116:e195-7. [PMID: 33167001 DOI: 10.1093/cvr/cvaa327] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
245 Rodríguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, Ramírez-Santana C, Costanzo A, Ridgway WM, Ansari AA, Gershwin ME, Selmi C, Anaya JM. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun 2020;114:102506. [PMID: 32563547 DOI: 10.1016/j.jaut.2020.102506] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 41.5] [Reference Citation Analysis]
246 Calabretta E, Moraleda JM, Iacobelli M, Jara R, Vlodavsky I, O'Gorman P, Pagliuca A, Mo C, Baron RM, Aghemo A, Soiffer R, Fareed J, Carlo-Stella C, Richardson P. COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br J Haematol 2021;193:43-51. [PMID: 33538335 DOI: 10.1111/bjh.17240] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
247 Cheruiyot I, Kipkorir V, Ngure B, Misiani M, Munguti J, Ogeng'o J. Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review. Ann Vasc Surg 2021;70:273-81. [PMID: 32866574 DOI: 10.1016/j.avsg.2020.08.087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
248 Vahedifard F, Chakravarthy K. Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19. Emergent Mater 2021;:1-25. [PMID: 33615140 DOI: 10.1007/s42247-021-00168-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
249 Kondo Y, Larabee JL, Gao L, Shi H, Shao B, Hoover CM, McDaniel JM, Ho YC, Silasi-Mansat R, Archer-Hartmann SA, Azadi P, Srinivasan RS, Rezaie AR, Borczuk A, Laurence JC, Lupu F, Ahamed J, McEver RP, Papin JF, Yu Z, Xia L. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI Insight 2021;6:148999. [PMID: 34291736 DOI: 10.1172/jci.insight.148999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Schmaier AA, Pajares Hurtado GM, Manickas-Hill ZJ, Sack KD, Chen SM, Bhambhani V, Quadir J, Nath AK, Collier AY, Ngo D, Barouch DH, Shapiro NI, Gerszten RE, Yu XG, Peters KG, Flaumenhaft R, Parikh SM; MGH COVID-19 Collection and Processing Team. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19. JCI Insight 2021;6:e151527. [PMID: 34506304 DOI: 10.1172/jci.insight.151527] [Reference Citation Analysis]
251 Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology 2021;162:30-43. [PMID: 32935333 DOI: 10.1111/imm.13262] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
252 Stokes JW, Gannon WD, Sherrill WH, Armistead LB, Bacchetta M, Rice TW, Semler MW, Casey JD. Bleeding, Thromboembolism, and Clinical Outcomes in Venovenous Extracorporeal Membrane Oxygenation. Crit Care Explor 2020;2:e0267. [PMID: 33196049 DOI: 10.1097/CCE.0000000000000267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
253 Bösmüller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch 2021;478:137-50. [PMID: 33604758 DOI: 10.1007/s00428-021-03053-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
254 Butiaeva LI, Slutzki T, Swick HE, Bourguignon C, Robins SC, Liu X, Storch KF, Kokoeva MV. Leptin receptor-expressing pericytes mediate access of hypothalamic feeding centers to circulating leptin. Cell Metab 2021;33:1433-1448.e5. [PMID: 34129812 DOI: 10.1016/j.cmet.2021.05.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
255 Croci GA, Vaira V, Trabattoni D, Biasin M, Valenti L, Baselli G, Barberis M, Guerini Rocco E, Gregato G, Scandroglio M, Fominskiy E, Palleschi A, Rosso L, Nosotti M, Clerici M, Ferrero S. Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients. Cells 2021;10:611. [PMID: 33801959 DOI: 10.3390/cells10030611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Alonso MN, Jareño Esteban JJ, García-león N. [Translated article] Pulmonary Vascular Tone Dysregulation and Microthrombosis in COVID-19. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2021.05.036] [Reference Citation Analysis]
257 Ari S, Can V, Demir ÖF, Ari H, Ağca FV, Melek M, Çamci S, Dikiş ÖŞ, Huysal K, Türk T. Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients. J Hematop 2020;:1-10. [PMID: 33046998 DOI: 10.1007/s12308-020-00419-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
258 Claesson-Welsh L, Dejana E, McDonald DM. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. Trends Mol Med 2021;27:314-31. [PMID: 33309601 DOI: 10.1016/j.molmed.2020.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
259 Kluck GEG, Yoo JA, Sakarya EH, Trigatti BL. Good Cholesterol Gone Bad? HDL and COVID-19. Int J Mol Sci 2021;22:10182. [PMID: 34638523 DOI: 10.3390/ijms221910182] [Reference Citation Analysis]
260 Mellema RA, Crandell J, Petrey AC. Platelet Dysregulation in the Pathobiology of COVID-19. Hamostaseologie 2021. [PMID: 34879421 DOI: 10.1055/a-1646-3392] [Reference Citation Analysis]
261 Boneva BP, Dimova MP, Nikolov NK, Stoyanova BI, Ilchev BN. Arterial thrombosis: the obscure threat in COVID-19 pandemic victims. Ital J Vasc Endovasc Surg 2021;28. [DOI: 10.23736/s1824-4777.21.01509-6] [Reference Citation Analysis]
262 McCarthy CG, Wilczynski S, Wenceslau CF, Webb RC. A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications. Vascul Pharmacol 2021;137:106826. [PMID: 33358968 DOI: 10.1016/j.vph.2020.106826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
263 Shadyro O, Samovich S, Edimecheva I, Novitsky R, Khrutskin V, Ihnatovich L, Boreko E, Dubovik B. Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation. Free Radic Res 2021;:1-12. [PMID: 34085882 DOI: 10.1080/10715762.2021.1938024] [Reference Citation Analysis]
264 Rodriguez-Cerdeira C, Uribe-Camacho BI, Silverio-Carrasco L, Méndez W, Mahesh AR, Tejada A, Beirana A, Martinez-Herrera E, Alba A, Arenas R, Szepietowski JC. Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries. Biology (Basel) 2021;10:54. [PMID: 33451000 DOI: 10.3390/biology10010054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
265 Santa S, Doku DA, Olwal CO, Brown CA, Tagoe EA, Quaye O. Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19? Future Microbiol 2022. [PMID: 35510478 DOI: 10.2217/fmb-2021-0233] [Reference Citation Analysis]
266 Spinetti G, Avolio E, Madeddu P. Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy? Regen Med 2021;16:477-94. [PMID: 33988482 DOI: 10.2217/rme-2020-0189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Rep 2020;6:871-4. [PMID: 32835045 DOI: 10.1016/j.jdcr.2020.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
268 Coate KC, Cha J, Shrestha S, Wang W, Gonçalves LM, Almaça J, Kapp ME, Fasolino M, Morgan A, Dai C, Saunders DC, Bottino R, Aramandla R, Jenkins R, Stein R, Kaestner KH, Vahedi G, Consortium H, Brissova M, Powers AC. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells. bioRxiv 2020:2020. [PMID: 33106804 DOI: 10.1101/2020.08.31.275719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
269 Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 2020;50:499-511. [PMID: 32700024 DOI: 10.1007/s11239-020-02230-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 38.5] [Reference Citation Analysis]
270 Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin. bioRxiv 2021:2021. [PMID: 33594363 DOI: 10.1101/2021.02.14.431174] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
271 Nomura E, Finn LS, Bauer A, Rozansky D, Iragorri S, Jenkins R, Al-Uzri A, Richardson K, Wright M, Kung VL, Troxell ML, Andeen NK. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol 2022. [PMID: 35166918 DOI: 10.1007/s00467-022-05457-w] [Reference Citation Analysis]
272 Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, Ribeiro da Silveira P, Tiwari S, Alzahrani KJ, Góes-Neto A, Azevedo V, Ghosh P, Barh D. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021;13:700. [PMID: 33919537 DOI: 10.3390/v13040700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
273 Booz GW, Altara R, Eid AH, Wehbe Z, Fares S, Zaraket H, Habeichi NJ, Zouein FA. Macrophage responses associated with COVID-19: A pharmacological perspective. Eur J Pharmacol 2020;887:173547. [PMID: 32919938 DOI: 10.1016/j.ejphar.2020.173547] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
274 Semiz S. SIT1 transporter as a potential novel target in treatment of COVID-19. Biomol Concepts 2021;12:156-63. [PMID: 34969185 DOI: 10.1515/bmc-2021-0017] [Reference Citation Analysis]
275 Spudich S, Nath A. Nervous system consequences of COVID-19. Science 2022;375:267-9. [PMID: 35050660 DOI: 10.1126/science.abm2052] [Reference Citation Analysis]
276 Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci 2021;78:5953-76. [PMID: 34223911 DOI: 10.1007/s00018-021-03889-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Evers G, Schulze AB, Osiaevi I, Harmening K, Vollenberg R, Wiewrodt R, Pistulli R, Boentert M, Tepasse PR, Sindermann JR, Yilmaz A, Mohr M. Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience. Can Respir J 2022;2022:2466789. [PMID: 35242250 DOI: 10.1155/2022/2466789] [Reference Citation Analysis]
278 Oxford AE, Halla F, Robertson EB, Morrison BE. Endothelial Cell Contributions to COVID-19. Pathogens 2020;9:E785. [PMID: 32992810 DOI: 10.3390/pathogens9100785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
279 Baltrūnas T, Račytė A, Pikturnaitė G, Skrebūnas A, Vaišnytė B. Aortic thrombosis after DVT and PE in a young COVID-19 patient. Ann Vasc Surg 2021:S0890-5096(21)00498-2. [PMID: 34411673 DOI: 10.1016/j.avsg.2021.07.005] [Reference Citation Analysis]
280 Guven G, Ince C, Topeli A, Caliskan K. Cardio-Pulmonary-Renal Consequences of Severe COVID-19. Cardiorenal Med 2021;11:133-9. [PMID: 34082420 DOI: 10.1159/000516740] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
281 Oliynyk O, Barg W, Slifirczyk A, Oliynyk Y, Dubrov S, Gurianov V, Rorat M. Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy. Life (Basel) 2021;11:1032. [PMID: 34685403 DOI: 10.3390/life11101032] [Reference Citation Analysis]
282 Sayed Ahmed HA, Merrell E, Ismail M, Joudeh AI, Riley JB, Shawkat A, Habeb H, Darling E, Goweda RA, Shehata MH, Amin H, Nieman GF, Aiash H. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Fam Med Community Health 2021;9:e000741. [PMID: 33879541 DOI: 10.1136/fmch-2020-000741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Savoia C, Volpe M, Kreutz R. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives. Circ Res 2021;128:1062-79. [PMID: 33793331 DOI: 10.1161/CIRCRESAHA.121.318054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
284 Agarwal S, Conway J, Nguyen V, Dogra S, Krieger P, Zagzag D, Lewis A, Melmed K, Galetta S, Jain R. Serial Imaging of Virus-Associated Necrotizing Disseminated Acute Leukoencephalopathy (VANDAL) in COVID-19. AJNR Am J Neuroradiol 2021;42:279-84. [PMID: 33093131 DOI: 10.3174/ajnr.A6898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
285 Tanacli R, Doeblin P, Götze C, Zieschang V, Faragli A, Stehning C, Korosoglou G, Erley J, Weiss J, Berger A, Pröpper F, Steinbeis F, Kühne T, Seidel F, Geisel D, Cannon Walter-Rittel T, Stawowy P, Witzenrath M, Klingel K, Van Linthout S, Pieske B, Tschöpe C, Kelle S. COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy. Front Cardiovasc Med 2021;8:737257. [PMID: 35004872 DOI: 10.3389/fcvm.2021.737257] [Reference Citation Analysis]
286 Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39:2529-2543. [PMID: 32654082 DOI: 10.1007/s10067-020-05275-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 31.0] [Reference Citation Analysis]
287 Oliveira TL, Melo IS, Cardoso-Sousa L, Santos IA, El Zoghbi MB, Shimoura CG, Georjutti RP, Castro OW, Goulart LR, Jardim ACG, Cunha TM, Sabino-Silva R. Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients. Front Physiol 2020;11:587013. [PMID: 33362575 DOI: 10.3389/fphys.2020.587013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
288 Nascimento Conde J, Schutt WR, Gorbunova EE, Mackow ER. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses. mBio 2020;11:e03185-20. [PMID: 33310781 DOI: 10.1128/mBio.03185-20] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
289 Yang JM, Moon SY, Lee JY, Agalliu D, Yon DK, Lee SW. COVID-19 morbidity and severity in patients with age-related macular degeneration: a Korean nationwide cohort study. Am J Ophthalmol 2021;:11881. [PMID: 34102151 DOI: 10.1016/j.ajo.2021.05.024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Kumar N, Zuo Y, Yalavarthi S, Hunker KL, Knight JS, Kanthi Y, Obi AT, Ganesh SK. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism. Viruses 2021;13:2209. [PMID: 34835015 DOI: 10.3390/v13112209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
291 Sarmiento-Monroy JC, Parra-Medina R, Garavito E, Rojas-Villarraga A. T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications. Viral Immunol 2021;34:190-200. [PMID: 33625297 DOI: 10.1089/vim.2020.0177] [Reference Citation Analysis]
292 Wagner JUG, Bojkova D, Shumliakivska M, Luxán G, Nicin L, Aslan GS, Milting H, Kandler JD, Dendorfer A, Heumueller AW, Fleming I, Bibli SI, Jakobi T, Dieterich C, Zeiher AM, Ciesek S, Cinatl J, Dimmeler S. Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Res Cardiol 2021;116:42. [PMID: 34224022 DOI: 10.1007/s00395-021-00882-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Li X, Xia WY, Jiang F, Liu DY, Lei SQ, Xia ZY, Wu QP. Review of the risk factors for SARS-CoV-2 transmission. World J Clin Cases 2021; 9(7): 1499-1512 [PMID: 33728294 DOI: 10.12998/wjcc.v9.i7.1499] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Whitmore HAB, Kim LA. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19). Am J Pathol 2021:S0002-9440(21)00260-1. [PMID: 34126084 DOI: 10.1016/j.ajpath.2021.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Reference Citation Analysis]
296 Goldin CJ, Vázquez R, Polack FP, Alvarez-Paggi D. Identifying pathophysiological bases of disease in COVID-19. Transl Med Commun 2020;5:15. [PMID: 32984543 DOI: 10.1186/s41231-020-00067-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Schimmel L, Chew KY, Stocks CJ, Yordanov TE, Essebier P, Kulasinghe A, Monkman J, Dos Santos Miggiolaro AFR, Cooper C, de Noronha L, Schroder K, Lagendijk AK, Labzin LI, Short KR, Gordon EJ. Endothelial cells are not productively infected by SARS-CoV-2. Clin Transl Immunology 2021;10:e1350. [PMID: 34721846 DOI: 10.1002/cti2.1350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
298 Poveda-Jaramillo R. Coronavirus disease 2019-induced hypercoagulability and its clinical implications. Asian Cardiovasc Thorac Ann 2021;:2184923211069185. [PMID: 34930050 DOI: 10.1177/02184923211069185] [Reference Citation Analysis]
299 Wang L, Astone M, Alam SK, Zhu Z, Pei W, Frank DA, Burgess SM, Hoeppner LH. Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability. Dis Model Mech 2021;14:dmm049029. [PMID: 34542605 DOI: 10.1242/dmm.049029] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
300 Santos A, Magro DO, Evangelista-Poderoso R, Saad MJA. Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications. Diabetol Metab Syndr 2021;13:23. [PMID: 33648564 DOI: 10.1186/s13098-021-00639-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
301 Braz-de-Melo HA, Faria SS, Pasquarelli-do-Nascimento G, Santos IO, Kobinger GP, Magalhães KG. The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19. Front Med (Lausanne) 2021;8:615333. [PMID: 33968948 DOI: 10.3389/fmed.2021.615333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Spinelli FR, Meylan F, O'Shea JJ, Gadina M. JAK inhibitors: Ten years after. Eur J Immunol 2021;51:1615-27. [PMID: 33930196 DOI: 10.1002/eji.202048922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
303 Kaufmann CC, Ahmed A, Kassem M, Freynhofer MK, Jäger B, Aicher G, Equiluz-Bruck S, Spiel AO, Funk GC, Gschwantler M, Fasching P, Wojta J, Huber K. Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19. Eur J Clin Invest 2021;51:e13531. [PMID: 33657664 DOI: 10.1111/eci.13531] [Reference Citation Analysis]
304 Brandão‐de‐resende C, Diniz‐filho A, Almeida Brito F, Vasconcelos‐santos DV. SARS‐CoV‐2 and COVID‐19 for the ophthalmologist. Clin Experiment Ophthalmol 2021;49:70-80. [DOI: 10.1111/ceo.13877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
305 Bianconi V, Mannarino MR, Figorilli F, Schiaroli E, Cosentini E, Batori G, Marini E, Sahebkar A, Grignani F, Gidari A, Francisci D, Pirro M. Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19. J Clin Med 2021;10:5456. [PMID: 34830738 DOI: 10.3390/jcm10225456] [Reference Citation Analysis]
306 Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, Akl EA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv 2021;5:872-88. [PMID: 33560401 DOI: 10.1182/bloodadvances.2020003763] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 65.0] [Reference Citation Analysis]
307 Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19. Int J Mol Sci 2020;21:E8234. [PMID: 33153161 DOI: 10.3390/ijms21218234] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
308 de Vries AAF. SARS-CoV-2/COVID-19: a primer for cardiologists. Neth Heart J 2020;28:366-83. [PMID: 32671650 DOI: 10.1007/s12471-020-01475-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
309 Li M, Qian M, Kyler K, Xu J. Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction. Front Cardiovasc Med 2021;8:681581. [PMID: 34277732 DOI: 10.3389/fcvm.2021.681581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
310 Steckelings UM, Sumners C. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci (Lond) 2020;134:2987-3006. [PMID: 33210709 DOI: 10.1042/CS20200922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
311 Sosa-Hernández VA, Torres-Ruíz J, Cervantes-Díaz R, Romero-Ramírez S, Páez-Franco JC, Meza-Sánchez DE, Juárez-Vega G, Pérez-Fragoso A, Ortiz-Navarrete V, Ponce-de-León A, Llorente L, Berrón-Ruiz L, Mejía-Domínguez NR, Gómez-Martín D, Maravillas-Montero JL. B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients. Front Immunol 2020;11:611004. [PMID: 33343585 DOI: 10.3389/fimmu.2020.611004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
312 Pasut A, Becker LM, Cuypers A, Carmeliet P. Endothelial cell plasticity at the single-cell level. Angiogenesis 2021;24:311-26. [PMID: 34061284 DOI: 10.1007/s10456-021-09797-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
313 Cooke JP, Connor JH, Jain A. Acute and Chronic Cardiovascular Manifestations of COVID-19: Role for Endotheliopathy. Methodist Debakey Cardiovasc J 2021;17:53-62. [PMID: 34992723 DOI: 10.14797/mdcvj.1044] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
314 Ermilov VV, Barkanov VB, Barkanova ON, Dorofeev NA, Filatov VE. [Clinical and anatomical features of SARS-COV-2 with acute hemorrhagic necrotizing encephalopathy]. Arkh Patol 2021;83:35-43. [PMID: 33512126 DOI: 10.17116/patol20218301135] [Reference Citation Analysis]
315 Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress. Front Physiol 2020;11:605908. [PMID: 33519510 DOI: 10.3389/fphys.2020.605908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
316 Ferlicot S, Jamme M, Gaillard F, Oniszczuk J, Couturier A, May O, Grünenwald A, Sannier A, Moktefi A, Le Monnier O, Petit-Hoang C, Maroun N, Brodin-Sartorius A, Michon A, Dobosziewicz H, Andreelli F, Guillet M, Izzedine H, Richard C, Dekeyser M, Arrestier R, Sthelé T, Lefèvre E, Mathian A, Legendre C, Mussini C, Verpont MC, Pallet N, Amoura Z, Essig M, Snanoudj R, Brocheriou-Spelle I, François H, Belenfant X, Geri G, Daugas E, Audard V, Buob D, Massy ZA, Zaidan M; AP-HP/Universities/Inserm COVID-19 research collaboration. The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury, and/or proteinuria. Nephrol Dial Transplant 2021:gfab042. [PMID: 33576823 DOI: 10.1093/ndt/gfab042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
317 Jain V, Chodankar RR, Maybin JA, Critchley HOD. Uterine bleeding: how understanding endometrial physiology underpins menstrual health. Nat Rev Endocrinol 2022. [PMID: 35136207 DOI: 10.1038/s41574-021-00629-4] [Reference Citation Analysis]
318 Rausch L, Lutz K, Schifferer M, Winheim E, Gruber R, Oesterhaus EF, Rinke L, Hellmuth JC, Scherer C, Muenchhoff M, Mandel C, Bergwelt-Baildon M, Simons M, Straub T, Krug AB, Kranich J, Brocker T. Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients. J Extracell Vesicles 2021;10:e12173. [PMID: 34854246 DOI: 10.1002/jev2.12173] [Reference Citation Analysis]
319 Romei C, Falaschi Z, Danna PSC, Airoldi C, Tonerini M, Rocchi E, Fanni SC, D'Amelio C, Barbieri G, Tiseo G, Arioli R, Paschè A, Karwoski RA, De Liperi A, Bartholmai BJ, Carriero A. Lung vessel volume evaluated with CALIPER software is an independent predictor of mortality in COVID-19 patients: a multicentric retrospective analysis. Eur Radiol 2022. [PMID: 35028751 DOI: 10.1007/s00330-021-08485-6] [Reference Citation Analysis]
320 Johnson AM, Barigye R, Saminathan H. Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases. Hum Vaccin Immunother 2021;17:2824-40. [PMID: 33974497 DOI: 10.1080/21645515.2021.1908060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
321 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021;12:67-79. [PMID: 33738009 DOI: 10.14740/cr1199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
322 Chapuy-regaud S, Allioux C, Capelli N, Migueres M, Lhomme S, Izopet J. Vectorial Release of Human RNA Viruses from Epithelial Cells. Viruses 2022;14:231. [DOI: 10.3390/v14020231] [Reference Citation Analysis]
323 Leslie-Mazwi TM, Srivatanakul K. Coronavirus disease 2019 and stroke. Interv Neuroradiol 2021;27:13-8. [PMID: 34670419 DOI: 10.1177/15910199211035920] [Reference Citation Analysis]
324 Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, Clapp C. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. J Biol Chem 2022;:101695. [PMID: 35143839 DOI: 10.1016/j.jbc.2022.101695] [Reference Citation Analysis]
325 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
326 Cherrie M, Clemens T, Colandrea C, Feng Z, Webb DJ, Weller RB, Dibben C. Ultraviolet A radiation and COVID-19 deaths in the USA with replication studies in England and Italy. Br J Dermatol 2021;185:363-70. [PMID: 33834487 DOI: 10.1111/bjd.20093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
327 Shakartalla SB, Alhumaidi RB, Shammout ODA, Al Shareef ZM, Ashmawy NS, Soliman SSM. Dyslipidemia in breast cancer patients increases the risk of SAR-CoV-2 infection. Infect Genet Evol 2021;92:104883. [PMID: 33905884 DOI: 10.1016/j.meegid.2021.104883] [Reference Citation Analysis]
328 Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, Zhang Y, Yin Q, Cho Y, Andrade L, Shadel GS, Hepokoski M, Lei T, Wang H, Zhang J, Yuan JX, Malhotra A, Manor U, Wang S, Yuan ZY, Shyy JY. SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE2. bioRxiv 2020:2020. [PMID: 33300001 DOI: 10.1101/2020.12.04.409144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
329 Al-Subaie AM. Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists. Saudi J Biol Sci 2021;28:956-61. [PMID: 33169062 DOI: 10.1016/j.sjbs.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Pivonello R, Auriemma RS, Pivonello C, Isidori AM, Corona G, Colao A, Millar RP. SEX DISPARITIES IN COVID-19 SEVERITY AND OUTCOME: ARE MEN WEAKER OR WOMEN STRONGER? Neuroendocrinology 2020. [PMID: 33242856 DOI: 10.1159/000513346] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
331 Lim MS, Mcrae S. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Crit Rev Oncol Hematol 2021;168:103529. [PMID: 34800652 DOI: 10.1016/j.critrevonc.2021.103529] [Reference Citation Analysis]
332 [DOI: 10.1101/2020.10.08.20209411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
333 Safai Zadeh E, Beutel B, Dietrich CF, Keber CU, Huber KP, Görg C, Trenker C. Perfusion Patterns of Peripheral Pulmonary Lesions in COVID-19 Patients Using Contrast-Enhanced Ultrasound (CEUS): A Case Series. J Ultrasound Med 2021. [PMID: 33459393 DOI: 10.1002/jum.15624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
334 Liana D, Phanumartwiwath A. Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention. J Nat Med 2021. [PMID: 34623617 DOI: 10.1007/s11418-021-01575-1] [Reference Citation Analysis]
335 Rochette L, Zeller M, Cottin Y, Vergely C. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism. Trends Endocrinol Metab 2021;32:875-89. [PMID: 34593305 DOI: 10.1016/j.tem.2021.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Bristogiannis S, Swan D, Thachil J. Thromboprophylaxis in COVID-19 - Rationale and considerations. Adv Biol Regul 2021;81:100819. [PMID: 34332403 DOI: 10.1016/j.jbior.2021.100819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 [DOI: 10.1101/2020.07.02.20144733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
338 Hamouche W, Bisserier M, Brojakowska A, Eskandari A, Fish K, Goukassian DA, Hadri L. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19. J Mol Cell Cardiol 2021;153:72-85. [PMID: 33373644 DOI: 10.1016/j.yjmcc.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
339 Maruhashi T, Higashi Y. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19. Int J Mol Sci 2021;22:5131. [PMID: 34066226 DOI: 10.3390/ijms22105131] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
340 Díaz-troyano N, Gabriel-medina P, Weber S, Klammer M, Barquín-delpino R, Castillo-ribelles L, Esteban A, Hernández-gonzález M, Ferrer-costa R, Pumarola T, Rodríguez-frías F. Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics 2022;12:886. [DOI: 10.3390/diagnostics12040886] [Reference Citation Analysis]
341 Ferrara F, Vitiello A. Efficacy of synthetic glucocorticoids in COVID-19 endothelites. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1003-7. [PMID: 33443616 DOI: 10.1007/s00210-021-02049-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
342 Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.Signal Transduct Target Ther. 2020;5:293. [PMID: 33361764 DOI: 10.1038/s41392-020-00454-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 27.5] [Reference Citation Analysis]
343 Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB. Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report. Cardiovasc Diabetol 2020;19:193. [PMID: 33203441 DOI: 10.1186/s12933-020-01165-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
344 Ram Kumar Pandian S, Arunachalam S, Deepak V, Kunjiappan S, Sundar K. Targeting complement cascade: an alternative strategy for COVID-19. 3 Biotech 2020;10:479. [PMID: 33088671 DOI: 10.1007/s13205-020-02464-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
345 Mahfoud S, Petrova TV. The double life of TLR2. Sci Signal 2021;14:eabf4701. [PMID: 34855457 DOI: 10.1126/scisignal.abf4701] [Reference Citation Analysis]
346 Benedetti F, Silvestri G, Mavian C, Weichseldorfer M, Munawwar A, Cash MN, Dulcey M, Vittor AY, Ciccozzi M, Salemi M, Latinovic OS, Zella D. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells. Viruses 2021;13:2193. [PMID: 34834998 DOI: 10.3390/v13112193] [Reference Citation Analysis]
347 Baris AM, Fraile-Bethencourt E, Anand S. Nucleic Acid Sensing in the Tumor Vasculature. Cancers (Basel) 2021;13:4452. [PMID: 34503262 DOI: 10.3390/cancers13174452] [Reference Citation Analysis]
348 Becker K, Beythien G, de Buhr N, Stanelle-Bertram S, Tuku B, Kouassi NM, Beck S, Zickler M, Allnoch L, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W. Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2. Front Immunol 2021;12:640842. [PMID: 33912167 DOI: 10.3389/fimmu.2021.640842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
349 Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, Miller V, Babich T, Shaked K, Ehrlich A, Ioannidis K, Nahmias Y, Sharan R, Ashery U, Maoz BM. Effect of SARS-CoV-2 proteins on vascular permeability. Elife 2021;10:e69314. [PMID: 34694226 DOI: 10.7554/eLife.69314] [Reference Citation Analysis]
350 Luban J, Sattler R, Mühlberger E, Graci JD, Cao L, Weetall M, Trotta C, Colacino JM, Bavari S, Strambio-De-Castillia C, Suder EL, Wang Y, Soloveva V, Cintron-Lue K, Naryshkin NA, Pykett M, Welch EM, O'Keefe K, Kong R, Goodwin E, Jacobson A, Paessler S, Peltz S. The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines. bioRxiv 2020:2020. [PMID: 32793904 DOI: 10.1101/2020.08.05.238394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
351 Ellison-Hughes GM, Colley L, O'Brien KA, Roberts KA, Agbaedeng TA, Ross MD. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.Front Cardiovasc Med. 2020;7:602183. [PMID: 33363221 DOI: 10.3389/fcvm.2020.602183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
352 Anca PS, Toth PP, Kempler P, Rizzo M. Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes. Int J Clin Pract 2021;75:e13666. [PMID: 32770758 DOI: 10.1111/ijcp.13666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
353 Kalafatis M. Covid-19: A Serious Vascular Disease With Primary Symptoms Of A Respiratory Ailment. J Appl Lab Med 2021:jfab084. [PMID: 34240194 DOI: 10.1093/jalm/jfab084] [Reference Citation Analysis]
354 Kaneko N, Satta S, Komuro Y, Muthukrishnan SD, Kakarla V, Guo L, An J, Elahi F, Kornblum HI, Liebeskind DS, Hsiai T, Hinman JD. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection. Stroke 2021;52:260-70. [PMID: 33161843 DOI: 10.1161/STROKEAHA.120.032764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
355 Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen AW. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis 2021. [PMID: 34184164 DOI: 10.1007/s10456-021-09805-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
356 Godoy LC, Goligher EC, Lawler PR, Slutsky AS, Zarychanski R. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ 2020;192:E1156-61. [PMID: 32816822 DOI: 10.1503/cmaj.201240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
357 McGowan EM, Haddadi N, Nassif NT, Lin Y. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci 2020;21:E7189. [PMID: 33003377 DOI: 10.3390/ijms21197189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
358 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell 2020;183:16-27.e1. [PMID: 32882182 DOI: 10.1016/j.cell.2020.08.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 67.0] [Reference Citation Analysis]
359 Akwii RG, Mikelis CM. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders. Drugs 2021;81:1731-49. [PMID: 34586603 DOI: 10.1007/s40265-021-01605-y] [Reference Citation Analysis]
360 Ahmetaj-Shala B, Vaja R, Atanur SS, George PM, Kirkby NS, Mitchell JA. Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells. JACC Basic Transl Sci 2020;5:1111-23. [PMID: 33073064 DOI: 10.1016/j.jacbts.2020.09.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
361 Rambaldi A, Gritti G, Micò MC, Frigeni M, Borleri G, Salvi A, Landi F, Pavoni C, Sonzogni A, Gianatti A, Binda F, Fagiuoli S, Di Marco F, Lorini L, Remuzzi G, Whitaker S, Demopulos G. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.Immunobiology. 2020;225:152001. [PMID: 32943233 DOI: 10.1016/j.imbio.2020.152001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
362 Arisan ED, Uysal-Onganer P, Lange S. Putative Roles for Peptidylarginine Deiminases in COVID-19. Int J Mol Sci 2020;21:E4662. [PMID: 32629995 DOI: 10.3390/ijms21134662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
363 Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021;9:e14726. [PMID: 33523608 DOI: 10.14814/phy2.14726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
364 Cheng R, Liu C, Yang J, Yang Y, Chen R, Ding X, Gao X, Ke J, Yuan F, He C, Shen Y, Zhang L, Li P, Tan H, Huang L. Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study. Front Physiol 2021;12:632123. [PMID: 33664674 DOI: 10.3389/fphys.2021.632123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Cicco S, Vacca A, Cariddi C, Carella R, Altamura G, Solimando AG, Lauletta G, Pappagallo F, Cirulli A, Stragapede A, Susca N, Grasso S, Ria R. Imaging Evaluation of Pulmonary and Non-Ischaemic Cardiovascular Manifestations of COVID-19. Diagnostics (Basel) 2021;11:1271. [PMID: 34359355 DOI: 10.3390/diagnostics11071271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Carbone M, Lednicky J, Xiao SY, Venditti M, Bucci E. Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For. J Thorac Oncol 2021;16:546-71. [PMID: 33422679 DOI: 10.1016/j.jtho.2020.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
367 Aschman T, Schneider J, Greuel S, Meinhardt J, Streit S, Goebel HH, Büttnerova I, Elezkurtaj S, Scheibe F, Radke J, Meisel C, Drosten C, Radbruch H, Heppner FL, Corman VM, Stenzel W. Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died. JAMA Neurol 2021;78:948-60. [PMID: 34115106 DOI: 10.1001/jamaneurol.2021.2004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Rovai ES, Alves T, Holzhausen M. Protease-activated receptor 1 as a potential therapeutic target for COVID-19. Exp Biol Med (Maywood) 2021;246:688-94. [PMID: 33302737 DOI: 10.1177/1535370220978372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
369 Mesquida J, Caballer A, Cortese L, Vila C, Karadeniz U, Pagliazzi M, Zanoletti M, Pacheco AP, Castro P, García-de-Acilu M, Mesquita RC, Busch DR, Durduran T; HEMOCOVID-19 Consortium. Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit Care 2021;25:381. [PMID: 34749792 DOI: 10.1186/s13054-021-03803-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Posada-Arango AM, García-Madrigal J, Echeverri-Isaza S, Alberto-Castrillón G, Martínez D, Gómez AC, Pinto JA, Pinillos L. Thrombosis in abdominal vessels associated with COVID-19 Infection: A report of three cases. Radiol Case Rep 2021;16:3044-50. [PMID: 34306276 DOI: 10.1016/j.radcr.2021.07.032] [Reference Citation Analysis]
371 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Federico L, de Biase D, Zippi M, Zancanaro M. COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Cytokine 2021;148:155628. [PMID: 34411989 DOI: 10.1016/j.cyto.2021.155628] [Reference Citation Analysis]
372 Griffioen AW, Dudley AC. Angiogenesis: a year in review. Angiogenesis 2021;24:195-6. [PMID: 34050879 DOI: 10.1007/s10456-021-09798-2] [Reference Citation Analysis]
373 Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. Immune responses during COVID-19 infection. Oncoimmunology 2020;9:1807836. [PMID: 32939324 DOI: 10.1080/2162402X.2020.1807836] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
374 Laouan Brem F, Asmae B, Amane Y, Bouazzaoui MA, Chaymae M, Rasras H, Nasri S, Abda N, Skiker I, Kouismi H, Zakaria B, Ismaili N, El Ouafi N. Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients. Clin Appl Thromb Hemost 2021;27:10760296211057901. [PMID: 34905979 DOI: 10.1177/10760296211057901] [Reference Citation Analysis]
375 Yang Q, Wijerathne H, Langston JC, Kiani MF, Kilpatrick LE. Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. Int J Mol Sci 2021;22:7770. [PMID: 34360536 DOI: 10.3390/ijms22157770] [Reference Citation Analysis]
376 Stratan L, Tiliscan C, Arama V, Lazar M, Visan A, Ganea O, Trifonescu MI, Arama SS, Ion D. COVID-19 associated coagulopathy is correlated with increased age and markers of inflammation response. Revista Romana de Medicina de Laborator 2021;29:387-94. [DOI: 10.2478/rrlm-2021-0031] [Reference Citation Analysis]
377 Roberts KA, Colley L, Agbaedeng TA, Ellison-Hughes GM, Ross MD. Vascular Manifestations of COVID-19 - Thromboembolism and Microvascular Dysfunction. Front Cardiovasc Med 2020;7:598400. [PMID: 33195487 DOI: 10.3389/fcvm.2020.598400] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
378 Constant O, Barthelemy J, Nagy A, Salinas S, Simonin Y. West Nile Virus Neuroinfection in Humans: Peripheral Biomarkers of Neuroinflammation and Neuronal Damage. Viruses 2022;14:756. [DOI: 10.3390/v14040756] [Reference Citation Analysis]
379 Rodríguez-hernández MÁ, Carneros D, Núñez-núñez M, Coca R, Baena R, López-ruiz GM, Cano-serrano ME, Martínez-tellería A, Fuentes-lópez A, Praena-fernandez JM, Garbers C, Hernández-quero J, García F, Rose-john S, Bustos M. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19. Front Immunol 2022;13:891456. [DOI: 10.3389/fimmu.2022.891456] [Reference Citation Analysis]
380 López-Escobar A, Madurga R, Castellano JM, Ruiz de Aguiar S, Velázquez S, Bucar M, Jimeno S, Ventura PS. Hemogram as marker of in-hospital mortality in COVID-19. J Investig Med 2021;69:962-9. [PMID: 33849952 DOI: 10.1136/jim-2021-001810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
381 Aleksova A, Gagno G, Sinagra G, Beltrami AP, Janjusevic M, Ippolito G, Zumla A, Fluca AL, Ferro F. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Int J Mol Sci 2021;22:4526. [PMID: 33926110 DOI: 10.3390/ijms22094526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
382 Zhou X, Cheng Z, Hu Y. COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management. J Pers Med 2021;11:1328. [PMID: 34945800 DOI: 10.3390/jpm11121328] [Reference Citation Analysis]
383 Fosse JH, Haraldsen G, Falk K, Edelmann R. Endothelial Cells in Emerging Viral Infections. Front Cardiovasc Med 2021;8:619690. [PMID: 33718448 DOI: 10.3389/fcvm.2021.619690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
384 Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11-30. [PMID: 33188364 DOI: 10.1038/s41574-020-00435-4] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 57.5] [Reference Citation Analysis]
385 Astapenko D, Tomasova A, Ticha A, Hyspler R, Chua HS, Manzoor M, Skulec R, Lehmann C, Hahn R, Malbrain ML, Cerny V. Endothelial glycocalyx damage in patients with severe COVID-19 on mechanical ventilation - a prospective observational pilot study. Clin Hemorheol Microcirc 2022. [PMID: 35342082 DOI: 10.3233/CH-221401] [Reference Citation Analysis]
386 Mancuso P, Gidaro A, Gregato G, Raveane A, Cremonesi P, Quarna J, Caccia S, Gusso L, Rusconi S, Giacomelli A, Cogliati C, Bertolini F. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases. J Thromb Haemost 2020;18:2744-50. [PMID: 32762140 DOI: 10.1111/jth.15044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
387 Barrett TJ, Bilaloglu S, Cornwell M, Burgess HM, Virginio VW, Drenkova K, Ibrahim H, Yuriditsky E, Aphinyanaphongs Y, Lifshitz M, Xia Liang F, Alejo J, Smith G, Pittaluga S, Rapkiewicz AV, Wang J, Iancu-Rubin C, Mohr I, Ruggles K, Stapleford KA, Hochman J, Berger JS. Platelets contribute to disease severity in COVID-19. J Thromb Haemost 2021. [PMID: 34538015 DOI: 10.1111/jth.15534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Tetlow S, Segiet-Swiecicka A, O'Sullivan R, O'Halloran S, Kalb K, Brathwaite-Shirley C, Alger L, Ankuli A, Baig MS, Catmur F, Chan T, Dudley D, Fisher J, Iqbal MU, Puczynska J, Wilkins R, Bygate R, Roberts P. ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19. J Intern Med 2021;289:688-99. [PMID: 33210357 DOI: 10.1111/joim.13202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
389 Schmaier AA, Hurtado GP, Manickas-Hill ZJ, Sack KD, Chen SM, Bhambhani V, Quadir J, Nath AK, Collier AY, Ngo D, Barouch DH, Gerszten RE, Yu XG, Peters K, Flaumenhaft R, Parikh SM; MGH COVID-19 Collection and Processing Team. Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19. medRxiv 2021:2021. [PMID: 34031665 DOI: 10.1101/2021.05.13.21257070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
390 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
391 Salminen AT, Tithof J, Izhiman Y, Masters EA, McCloskey MC, Gaborski TR, Kelley DH, Pietropaoli AP, Waugh RE, McGrath JL. Endothelial cell apicobasal polarity coordinates distinct responses to luminally versus abluminally delivered TNF-α in a microvascular mimetic. Integr Biol (Camb) 2020;12:275-89. [PMID: 33164044 DOI: 10.1093/intbio/zyaa022] [Reference Citation Analysis]
392 Schiaffino S, Codari M, Cozzi A, Albano D, Alì M, Arioli R, Avola E, Bnà C, Cariati M, Carriero S, Cressoni M, Danna PSC, Della Pepa G, Di Leo G, Dolci F, Falaschi Z, Flor N, Foà RA, Gitto S, Leati G, Magni V, Malavazos AE, Mauri G, Messina C, Monfardini L, Paschè A, Pesapane F, Sconfienza LM, Secchi F, Segalini E, Spinazzola A, Tombini V, Tresoldi S, Vanzulli A, Vicentin I, Zagaria D, Fleischmann D, Sardanelli F. Machine Learning to Predict In-Hospital Mortality in COVID-19 Patients Using Computed Tomography-Derived Pulmonary and Vascular Features. J Pers Med 2021;11:501. [PMID: 34204911 DOI: 10.3390/jpm11060501] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
393 Abowali H, Pacifico A, Erdnic B, Elkholy K, Burkhanova U, Aroriode T, Watson A, Ahmed F, Uwagbale E, Visweshwar N, Jaglal M. Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population—Bleeding Risk Factors in COVID-19 Patients. JCM 2022;11:2754. [DOI: 10.3390/jcm11102754] [Reference Citation Analysis]
394 Tehrani HA, Darnahal M, Vaezi M, Haghighi S. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review. Int Immunopharmacol 2021;93:107397. [PMID: 33524803 DOI: 10.1016/j.intimp.2021.107397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
395 Yang K, Holt M, Fan M, Lam V, Yang Y, Ha T, Williams DL, Li C, Wang X. Cardiovascular Dysfunction in COVID-19: Association Between Endothelial Cell Injury and Lactate. Front Immunol 2022;13:868679. [DOI: 10.3389/fimmu.2022.868679] [Reference Citation Analysis]
396 Prakash J, Khan MS, Kumar R, Bhattacharya PK, Banerjee S, Nirala DK. High-flow Nasal Oxygen Therapy in COVID-19 Critically Ill Patients with Acute Hypoxemic Respiratory Failure: A Prospective Observational Cohort Study. Indian Journal of Critical Care Medicine 2022;26:594-601. [DOI: 10.5005/jp-journals-10071-24167] [Reference Citation Analysis]
397 Luft T, Wendtner CM, Kosely F, Radujkovic A, Benner A, Korell F, Kihm L, Bauer MF, Dreger P, Merle U. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients. Front Immunol 2021;12:634416. [PMID: 34248931 DOI: 10.3389/fimmu.2021.634416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
398 Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis. Viruses 2021;13:2324. [PMID: 34835130 DOI: 10.3390/v13112324] [Reference Citation Analysis]
399 Anipindi M, Scott A, Joyce L, Wali S, Morginstin M. Case Report: Cerebral Venous Sinus Thrombosis and COVID-19 Infection. Front Med (Lausanne) 2021;8:741594. [PMID: 34722579 DOI: 10.3389/fmed.2021.741594] [Reference Citation Analysis]
400 Ceci Bonello E, Casha R, Xerri T, Bonello J, Fsadni C, Mallia Azzopardi C. Multiorgan thrombosis as a complication of COVID-19 pneumonia. BMJ Case Rep 2021;14:e243953. [PMID: 34321271 DOI: 10.1136/bcr-2021-243953] [Reference Citation Analysis]
401 Martinez FO, Combes TW, Orsenigo F, Gordon S. Monocyte activation in systemic Covid-19 infection: Assay and rationale. EBioMedicine 2020;59:102964. [PMID: 32861199 DOI: 10.1016/j.ebiom.2020.102964] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
402 Matheson NJ, Lehner PJ. How does SARS-CoV-2 cause COVID-19? Science. 2020;369:510-511. [PMID: 32732413 DOI: 10.1126/science.abc6156] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 37.5] [Reference Citation Analysis]
403 Reusch N, De Domenico E, Bonaguro L, Schulte-Schrepping J, Baßler K, Schultze JL, Aschenbrenner AC. Neutrophils in COVID-19. Front Immunol 2021;12:652470. [PMID: 33841435 DOI: 10.3389/fimmu.2021.652470] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
404 Worth H, Helmlinger K, Raj R, Heidel E, Lands R. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study. Clin Appl Thromb Hemost 2021;27:10760296211053315. [PMID: 34786969 DOI: 10.1177/10760296211053315] [Reference Citation Analysis]
405 Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021;22:e13313. [PMID: 34269511 DOI: 10.1111/obr.13313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 Mercier MR, Galivanche AR, Brand JP, Pathak N, Medvecky MJ, Varthi AG, Rubin LE, Grauer JN. COVID-positive ankle fracture patients are at increased odds of perioperative surgical complications following open reduction internal fixation surgery. PLoS One 2021;16:e0262115. [PMID: 34972190 DOI: 10.1371/journal.pone.0262115] [Reference Citation Analysis]
407 Amado-Azevedo J, van Stalborch AD, Valent ET, Nawaz K, van Bezu J, Eringa EC, Hoevenaars FPM, De Cuyper IM, Hordijk PL, van Hinsbergh VWM, van Nieuw Amerongen GP, Aman J, Margadant C. Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation. Angiogenesis 2021;24:677-93. [PMID: 33770321 DOI: 10.1007/s10456-021-09781-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
408 Del Borrello G, Giraudo I, Bondone C, Denina M, Garazzino S, Linari C, Mignone F, Pruccoli G, Scolfaro C, Spadea M, Pollio B, Saracco P. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study. J Thromb Haemost 2021;19:522-30. [PMID: 33305475 DOI: 10.1111/jth.15216] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
409 Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol 2021. [PMID: 34235728 DOI: 10.1111/bph.15587] [Reference Citation Analysis]
410 Prasanna PG, Woloschak GE, DiCarlo AL, Buchsbaum JC, Schaue D, Chakravarti A, Cucinotta FA, Formenti SC, Guha C, Hu DJ, Khan MK, Kirsch DG, Krishnan S, Leitner WW, Marples B, McBride W, Mehta MP, Rafii S, Sharon E, Sullivan JM, Weichselbaum RR, Ahmed MM, Vikram B, Coleman CN, Held KD. Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? Radiat Res 2020;194:452-64. [PMID: 33045077 DOI: 10.1667/RADE-20-00211.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
411 Williams GW, Berg NK, Reskallah A, Yuan X, Eltzschig HK. Acute Respiratory Distress Syndrome. Anesthesiology 2021;134:270-82. [PMID: 33016981 DOI: 10.1097/ALN.0000000000003571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
412 Jessop F, Schwarz B, Scott D, Roberts LM, Bohrnsen E, Hoidal JR, Bosio CM. Impairing RAGE signaling promotes survival and limits disease pathogenesis following SARS-CoV-2 infection in mice. JCI Insight 2022;7:e155896. [DOI: 10.1172/jci.insight.155896] [Reference Citation Analysis]
413 Gawałko M, Kapłon-Cieślicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc 2020;30:100631. [PMID: 32904969 DOI: 10.1016/j.ijcha.2020.100631] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
414 Gawaz A, Guenova E. Microvascular Skin Manifestations Caused by COVID-19. Hamostaseologie 2021;41:387-96. [PMID: 34695855 DOI: 10.1055/a-1581-6899] [Reference Citation Analysis]
415 Stevens RP, Paudel SS, Johnson SC, Stevens T, Lee JY. Endothelial metabolism in pulmonary vascular homeostasis and acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2021;321:L358-76. [PMID: 34159794 DOI: 10.1152/ajplung.00131.2021] [Reference Citation Analysis]
416 Kalicińska E, Biernat M, Rybka J, Zińczuk A, Janocha-Litwin J, Rosiek-Biegus M, Morawska M, Waszczuk-Gajda A, Drozd-Sokołowska J, Szukalski Ł, Rymko M, Jabłonowska P, Simon K, Wróbel T. Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study. J Clin Med 2021;10:4373. [PMID: 34640390 DOI: 10.3390/jcm10194373] [Reference Citation Analysis]
417 Mancini I, Baronciani L, Artoni A, Colpani P, Biganzoli M, Cozzi G, Novembrino C, Boscolo Anzoletti M, De Zan V, Pagliari MT, Gualtierotti R, Aliberti S, Panigada M, Grasselli G, Blasi F, Peyvandi F. The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost 2021;19:513-21. [PMID: 33230904 DOI: 10.1111/jth.15191] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
418 Marcos S, Albiñana V, Recio-Poveda L, Tarazona B, Verde-González MP, Ojeda-Fernández L, Botella LM. SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population. J Clin Med 2021;10:1884. [PMID: 33925423 DOI: 10.3390/jcm10091884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]